Hector DeLuca

Q: What Schools Are Affiliated With Hector DeLuca

Hector DeLuca is affiliated with the following schools: University of Oxford, University of Wisconsin–Madison

Hector DeLuca's AcademicInfluence.com Rankings

Hector DeLuca

Biology

#502

World Rank

#879

Historical Rank

#295

USA Rank

Biochemistry

#23

World Rank

#31

Historical Rank

#15

USA Rank

biology Degrees

Download Badge

Biology

Why Is Hector DeLuca Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Hector F. DeLuca, born in Pueblo, Colorado in 1930, is an emeritus University of Wisconsin–Madison professor and former chairman of the university's biochemistry department. DeLuca is well known for his research in involving Vitamin D, from which several pharmaceutical drugss are derived. He was elected to the United States National Academy of Sciences in 1979.

(See a Problem?)

Hector DeLuca's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Overview of general physiologic features and functions of vitamin D. (2004) (2158)
Current understanding of the molecular actions of vitamin D. (1998) (1225)
Vitamin D: its role and uses in immunology 1 (2001) (862)
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. (1979) (814)
1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. (1996) (762)
The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. (1973) (722)
Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. (1979) (718)
Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. (2000) (684)
1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture (1972) (588)
Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. (1972) (586)
Metabolism and mechanism of action of vitamin D. (1976) (565)
The vitamin D story: a collaborative effort of basic science and clinical medicine 1 (1988) (530)
A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. (1976) (491)
25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. (1968) (471)
The role of vitamin A in mammalian reproduction and embryonic development. (2002) (447)
Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. (1990) (436)
1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. (1998) (432)
Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. (1971) (425)
Vitamin D, disease and therapeutic opportunities (2010) (418)
Vitamin D: recent advances. (1983) (411)
Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. (1980) (406)
Calcium uptake by rat kidney mitochondria. (1961) (406)
Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol. (1971) (386)
Pathogenesis of Hereditary Vitamin-D-Dependent Rickets (1973) (381)
Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. (1992) (379)
Determination of vitamin D and its metabolites in plasma from normal and anephric man. (1979) (352)
"Activation" of vitamin D by the liver. (1969) (342)
Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. (1977) (336)
Where is the vitamin D receptor? (2002) (311)
Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. (1994) (307)
Biological activity of 25-hydroxyergocalciferol in rats. (1970) (300)
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. (1978) (300)
Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. (1972) (291)
Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. (1979) (282)
DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. (1990) (276)
Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. (1995) (274)
Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. (2002) (272)
1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. (1998) (268)
Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. (1992) (258)
The role of the liver in the metabolism of vitamin D. (1969) (257)
Vitamin D Metabolism: The Role of Kidney Tissue (1971) (256)
A ligand for the aryl hydrocarbon receptor isolated from lung (2002) (250)
Influence of sodium on calcium transport by the rat small intestine. (1969) (247)
Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. (1984) (246)
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. (1998) (244)
Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. (1971) (243)
The vitamin D system in the regulation of calcium and phosphorus metabolism. (2009) (240)
Biologically active metabolite of vitamin D3 from bone, liver, and blood serum. (1966) (239)
CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo (2013) (239)
Is the vitamin d receptor found in muscle? (2011) (238)
Evolution of our understanding of vitamin D. (2008) (235)
The rapid incorporation of phosphate into mitochondrial lipids. (1963) (233)
A rapid assay for 25-OH-vitamin D3 without preparative chromatography. (1974) (231)
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. (1983) (226)
Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. (1978) (226)
Brain target sites for 1,25-dihydroxyvitamin D3. (1982) (226)
A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone. (1977) (224)
Competitive binding assay for vitamin D and 25-OH vitamin D. (1971) (222)
Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization. (1992) (217)
Biological activity of 1,25-dihydroxycholecalciferol. (1971) (215)
Mechanisms and functions of vitamin D. (2009) (214)
25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties. (1972) (212)
Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. (1980) (210)
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. (1972) (209)
Regulation of vitamin D metabolism and function. (1973) (201)
Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats. (1974) (201)
A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite. (1971) (200)
Vitamin D: the vitamin and the hormone. (1974) (197)
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production (2010) (197)
Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. (1983) (192)
Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme. (1996) (191)
History of the discovery of vitamin D and its active metabolites. (2014) (190)
Cloning and expression of rat 25-hydroxyvitamin D3-1α-hydroxylase cDNA (1997) (186)
1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. (1973) (185)
Bone mineral mobilization activity of 1,25-dihydroxycholecalciferol, a metabolite of vitamin D. (1971) (183)
An investigation of sources of variation in calcium absorption efficiency. (1995) (183)
Two Vitamin D Response Elements Function in the Rat 1,25-Dihydroxyvitamin D 24-Hydroxylase Promoter (*) (1995) (183)
Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood. (1980) (181)
1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay. (1976) (179)
Mitochondrial Cytochrome P450 A COMPONENT OF CHICK KIDNEY 25-HYDROXYCHOLECALCIFEROL-1α-HYDROXYLASE (1974) (178)
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D (2018) (178)
Vitamin D-regulated gene expression. (1993) (177)
Vitamin D metabolism and function. (1979) (177)
Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. (1978) (176)
Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. (2003) (175)
Vitamin D of human milk: identification of biologically active forms. (1982) (175)
Identification of a 1,25-dihydroxyvitamin D3-response element in the 5'-flanking region of the rat calbindin D-9k gene. (1992) (175)
In vitro production of 25-hydroxycholecalciferol. (1969) (174)
1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. (1982) (174)
25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties. (1974) (173)
Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. (1977) (172)
Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. (1980) (172)
Recent advances in our understanding of the vitamin D endocrine system. (1979) (170)
Vitamin D is necessary for reproductive functions of the male rat. (1989) (168)
Vitamin D and autoimmune diabetes (2003) (167)
Subcellular location of rat liver calciferol-25-hydroxylase. (1974) (165)
Vitamin D stimulation of calcium-dependent adenosine triphosphatase in chick intestinal brush borders. (1970) (165)
Regulation of metabolism of 25-hydroxycholecalciferol by kidney tissue in vitro by dietary calcium. (1972) (163)
Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. (1981) (163)
1 alpha-Hydroxylated cholecalciferol compounds act additively with microbial phytase to improve phosphorus, zinc and manganese utilization in chicks fed soy-based diets. (1995) (163)
Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. (2004) (163)
Stimulation of 24,25-Dihydroxyvitamin D3 Production by 1,25-Dihydroxyvitamin D3 (1974) (161)
Vitamin D is not directly necessary for bone growth and mineralization. (1984) (160)
Rickets with alopecia: an inborn error of vitamin D metabolism. (1979) (159)
Role of vitamin D metabolites in phosphate transport of rat intestine. (1974) (159)
Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. (2014) (158)
Molecular Cloning of cDNA and Genomic DNA for Human 25-hydroxyvitamin D31α-hydroxylase (1997) (156)
Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. (1967) (156)
The Fat-Soluble Vitamins (1970) (155)
A potent analog of 1α,25-dihydroxyvitamin D3 selectively induces bone formation (2002) (155)
1,25-Dihydroxycholecalciferol: Metabolite of Vitamin D3 Active on Bone in Anephric Rats (1972) (155)
The regulation of rat liver calciferol-25-hydroxylase. (1973) (154)
Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion. (1976) (152)
1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. (1983) (152)
Vitamin D deficiency suppresses cell-mediated immunity in vivo. (1993) (150)
25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity. (1970) (149)
Control of renal vitamin D hydroxylases in birds by sex hormones. (1976) (149)
Evidence that 1,25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3. (1985) (148)
The role of 1,25-dihydroxyvitamin D3 and parathyroid hormone in the regulation of chick renal 25-hydroxyvitamin D3-24-hydroxylase. (1975) (148)
Vitamin D receptor null mutant mice fed high levels of calcium are fertile. (2001) (147)
Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene. (1994) (147)
Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. (2000) (147)
1α-Hydroxy Derivative of Vitamin D3: A Highly Potent Analog of 1α,25-Dihydroxyvitamin D3 (1973) (146)
Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D3 stimulated calcium absorption and clarify its immunomodulatory properties (2004) (146)
Vitamin A antagonizes the action of vitamin D in rats. (1999) (145)
Vitamin D 25-hydroxylase - Four decades of searching, are we there yet? (2012) (145)
Defects in embryonic hindbrain development and fetal resorption resulting from vitamin A deficiency in the rat are prevented by feeding pharmacological levels of all-trans-retinoic acid. (1998) (145)
1α,25-dihydroxy-19-nor-vitamin D3, a novel vitamin D-related compound with potential therapeutic activity (1990) (144)
Stimulation of intestinal calcium transport and bone calcium mobilization by prolactin in vitamin D-deficient rats. (1981) (144)
Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. (2008) (143)
Mechanism of action and metabolic fate of vitamin D. (1967) (142)
Calcium transport in small intestine during pregnancy and lactation. (1980) (141)
Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes. (1980) (140)
Influence of dietary phosphorus on renal phosphate reabsorption in the parathyroidectomized rat. (1976) (140)
New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. (1998) (139)
Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. (1975) (138)
Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. (1993) (138)
Intestinal cytosol binders of 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D. (1976) (137)
Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. (1999) (136)
Vitamin D metabolism during pregnancy and lactation in the rat. (1979) (135)
25-Hydroxycholecalciferol: Stimulation of Bone Resorption in Tissue Culture (1969) (133)
Vitamin D. Basic research and its clinical application. (1979) (132)
The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat. (1966) (132)
Role of 1,25-dihydroxyvitamin D3 in maintaining serum phosphorus and curing rickets. (1974) (128)
The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone. (1973) (128)
High-pressure liquid chromatography: separation of the metabolites of vitamins D2 and D3 on small-particle silica columns. (1975) (125)
Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus. (1984) (125)
Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. (1988) (125)
In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue. (1979) (124)
Isolation of chick renal mitochondrial ferredoxin active in the 25-hydroxyvitamin D3-1alpha-hydroxylase system. (1976) (123)
Cellular and subcellular localization of 1,25-(OH)2-vitamin D3 in rat kidney: comparison with localization of parathyroid hormone and estradiol. (1980) (122)
Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats. (1999) (122)
Appearance of the intestinal cytosolic receptor for 1,25-dihydroxyvitamin D3 during neonatal development in the rat. (1981) (121)
A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. (1978) (121)
The Biological Activity and Metabolism of 24,25-Dihydroxyvitamin D3 (1973) (118)
Regulation of 25‐hydroxyvitamin D3‐24‐hydroxylase mRNA by 1,25‐dihydroxyvitamin D3 and parathyroid hormone (2003) (118)
Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. (1968) (117)
Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. (1998) (117)
An estrogen-responsive element mediates the transcriptional regulation of calbindin D-9K gene in rat uterus. (1991) (117)
The stimulation of 25-hydroxyvitamin D3-1α-hydroxylase by estrogen☆ (1977) (116)
Minireview: Vitamin D: is there a role in extraskeletal health? (2011) (116)
Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. (2010) (114)
The effect of age on calcium absorption and accumulation of 1,25-hydroxyvitamin D3 in intestinal mucosa of rats (1978) (114)
Rat intestinal 25-hydroxyvitamin D3- and 1alpha,25-dihydroxyvitamin D3-24-hydroxylase. (1978) (113)
Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults. (1978) (111)
Vitamin D stimulated, calcium-dependent adenosine triphosphatase from brush borders of rat small intestine. (1969) (111)
Strontium Induced Rickets: Metabolic Basis (1971) (110)
Specific cytosol-binding protein for 1,25-dihydroxyvitamin D3 in rat intestine. (1977) (109)
21,25-dihydroxycholecalciferol. A metabolite of vitamin D3 preferentially active on bone. (1970) (109)
Regulation of bone mineral loss during lactation. (1985) (109)
Isolation and identification of 1,25-dihydroxyvitamin D2. (1975) (106)
Monoclonal antibodies to the porcine intestinal receptor for 1,25-dihydroxyvitamin D3: interaction with distinct receptor domains. (1986) (105)
Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin. (1980) (105)
Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. (1991) (105)
Vitamin D3 from rat skins irradiated in vitro with ultraviolet light. (1978) (105)
Biological activity of 1,25-dihydroxyvitamin D3 in the rat. (1973) (105)
Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogs. (1987) (104)
The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆ (2002) (104)
The essentiality of vitamin D metabolites for embryonic chick development. (1978) (104)
The synthesis of 1α,25-dihydroxycholecalciferol -- A metabolically active form of vitamin D3 (1972) (102)
Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders. (1980) (102)
The Acute Renal Tubular Effects of 1,25-Dihydroxycholecalciferol (1972) (102)
1α-Hydroxyvitamin D2 is Less Toxic than 1α-Hydroxyvitamin D3 in the Rat (1985) (101)
1,25-dihydroxycholecalciferol: the metabolite of vitamin D responsible for increased intestinal calcium transport. (1971) (101)
Actinomycin D Inhibition of Vitamin D Action (1965) (100)
Normalization of serum calcium restores fertility in vitamin D-deficient male rats. (1992) (100)
1,25-Dihydroxyvitamin D3 restores fertility of vitamin D-deficient female rats. (1989) (100)
Isolation and characterization of 1 alpha-hydroxy-23-carboxytetranorvitamin D: a major metabolite of 1,25-dihydroxyvitamin D3. (1979) (100)
Immunocytology with microwave-fixed fibroblasts shows 1 alpha,25- dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors (1990) (99)
Characteristics of the rat liver microsomal enzyme system converting cholecalciferol into 25-hydroxycholecalciferol. Evidence for the participation of cytochrome p-450. (1979) (99)
Rachitogenic activity of dietary strontium. I. Inhibition of intestinal calcium absorption and 1,25-dihydroxycholecalciferol synthesis. (1972) (99)
25-Hydroxycholecalciferol: Direct Effect on Calcium Transport (1969) (99)
The synthesis of 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. (1969) (99)
The p38 and JNK Pathways Cooperate to trans-Activate Vitamin D Receptor via c-Jun/AP-1 and Sensitize Human Breast Cancer Cells to Vitamin D3-induced Growth Inhibition* (2002) (98)
Structure and regulation of the rat 1,25-dihydroxyvitamin D3 receptor. (1988) (98)
Vitamin D and Multiple Sclerosis (1997) (98)
1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. (2011) (97)
26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3: a highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3. (1984) (97)
1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo. (1989) (95)
ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. (1993) (95)
Formation of retinoic acid from retinol in the rat. (1967) (95)
25-Hydroxycholecalciferol-1-hydroxylase: a specific requirement for NADPH and a hemoprotein component in chick kidney mitochondria. (1974) (93)
The metabolism and functions of vitamin D. (1986) (92)
Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. (1980) (92)
Determination of stereochemical configuration of the 24-hydroxyl group of 24,25-dihydroxyvitamin D3 and its biological importance. (1975) (92)
Intestinal calcium absorption in the aged rat: evidence of intestinal resistance to 1,25(OH)2 vitamin D. (1998) (91)
In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). (2000) (91)
Liquid-gel partition chromatography of vitamin A compounds; formation of retinoic acid from retinyl acetate in vivo. (1974) (91)
The Preparation of H 3 -Vitamins D 2 and D 3 and Their Localization in the Rat * (1963) (90)
Calcium transport and the role of vitamin D. (1969) (90)
Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. (1993) (89)
Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. (1982) (89)
Target cells for 1,25 dihydroxyvitamin D3 in the pancreas (2004) (88)
Biological activity of 24,24-difluoro-25-hydroxyvitamin D3. Effect of blocking of 24-hydroxylation on the functions of vitamin D. (1979) (87)
2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 Potently Stimulates Gene-specific DNA Binding of the Vitamin D Receptor in Osteoblasts* (2003) (87)
1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. (1998) (87)
YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene. (1997) (87)
Intestinal 1,25-dihydroxyvitamin D3 binding protein: Specificity of binding (1977) (87)
Skeletal changes during pregnancy and lactation: the role of vitamin D. (1980) (86)
25-Hydroxyvitamin D3 26,23-lactone: a new in vivo metabolite of vitamin D. (1979) (85)
Association Between Intestinal Vitamin D Receptor, Calcium Absorption, and Serum 1,25 Dihydroxyvitamin D in Normal Young and Elderly Women (1997) (85)
Metabolism of 1,25-dihydroxyvitamin D3: evidence for side-chain oxidation. (1976) (85)
Calbindin D9k knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level (2006) (84)
The effect of hepatectomy on the synthesis of 25-hydroxyvitamin D3. (1976) (83)
The isolation and identification of 25-hydroxyergocalciferol. (1969) (83)
Decreased c-myc expression is an early event in retinoic acid-induced differentiation of F9 teratocarcinoma cells. (1986) (83)
Assessment of 25-hydroxyvitamin D 1 alpha-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract. (1981) (83)
The 24-hydroxylation of 1,25-dihydroxyvitamin D3. (1977) (83)
Vitamin D deficiency and reproduction in rats. (1979) (82)
The acute effect of 25-hydroxycholecalciferol on renal handling of phosphorus. Evidence for a parathyroid hormone-dependent mechanism. (1974) (82)
Retinoic acid is detected at relatively high levels in the CNS of adult rats. (2002) (82)
Mechanism of action of 1,25-dihydroxycholecalciferol on intestinal calcium transport. (1971) (81)
Parathyroid hormone regulates 25-hydroxyvitamin D3-24-hydroxylase mRNA by altering its stability (2001) (81)
The Sp1 transcription factor gene (SP1) and the 1,25-dihydroxyvitamin D3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. (1991) (81)
The influence of dietary calcium and phosphorus on intestinal calcium transport in rats given vitamin D metabolites. (1975) (81)
TRPV6 is not required for 1α,25-dihydroxyvitamin D3-induced intestinal calcium absorption in vivo (2008) (80)
Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets. (1980) (80)
Lithocholic acid can carry out in vivo functions of vitamin D (2007) (80)
Calbindin D9k is not required for 1,25-dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine. (2007) (79)
Phosphatemic action of 1,25-dihydroxyvitamin D3. (1975) (79)
Vitamin D stimulated calcium binding protein from rat intestinal mucosa. Purification and some properties. (1971) (79)
Identification of a highly specific and versatile vitamin D receptor antibody. (2010) (78)
Phosphorylation of the 1,25-dihydroxyvitamin D3 receptor. A primary event in 1,25-dihydroxyvitamin D3 action. (1990) (78)
Biological activity of a vitamin D metabolite (1967) (78)
The action of vitamin D and parathyroid hormone in vitro on calcium uptake and release by kidney mitochondria. (1962) (78)
Metabolism of Vitamin D (1979) (77)
Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. (1973) (77)
Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium (2003) (76)
Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. (1996) (76)
Pathways of retinol and retinoic acid metabolism in the rat. (1967) (76)
BIOLOGICALLY ACTIVE FORMS OF VITAMIN D3 IN KIDNEY AND INTESTINE. (1964) (75)
The determination of the vitamin D metabolites on a single plasma sample: changes during parturition in dairy cows. (1979) (74)
Dietary calcium deficiency : A syndrome associated with bone deformities and elevated serum 1,25-Dihyroxyvitamin D concentrations (1981) (74)
Vitamin D: Historical Overview. (2016) (74)
A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements. (1992) (73)
Isolation and identification of 5, 6-epoxyretinoic acid: a biologically active metabolite of retinoic acid. (1978) (73)
CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin. (2006) (73)
The vitamin D system: 1990. (1990) (73)
Metabolism of vitamin D: current status. (1976) (73)
Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density (1995) (72)
1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components* (2015) (72)
Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. (2003) (71)
24- and 26-homo-1,25-dihydroxyvitamin D3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. (1987) (71)
The determination of 24,25-dihydroxyvitamin D and 25,26-dihydroxyvitamin D in plasma from normal and nephrectomized man. (1979) (71)
Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindreds (1993) (70)
Vitamin D metabolite levels in oncogenic osteomalacia. (1980) (70)
The physiologic significance of plasma transport of vitamin D and metabolites. (1974) (70)
Intestinal Calcium Transport: Stimulation by Low Phosphorus Diets (1973) (70)
The Metabolism, Physiology, and Function of Vitamin D (1984) (69)
Calcitriol corrects bone loss induced by oophorectomy in rats. (1986) (69)
24-homologated 1,25-dihydroxyvitamin D3 compounds: separation of calcium and cell differentiation activities. (1990) (69)
On the relationship between vitamin D action and actinomycin-sensitive processes. (1966) (68)
Synthesis of (26,27- 3 H)-25-hydroxycholecalciferol. (1971) (67)
Metabolites of vitamin D3 and their biologic activity. (1969) (67)
The kidney as an endocrine organ involved in the function of vitamin D. (1975) (66)
Effects of increasing doses of 1α‐hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women (1994) (66)
Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice (2012) (66)
Vitamin D compounds in cows' milk. (1982) (66)
Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects. (1978) (66)
Synergistic effect of progesterone, testosterone, and estradiol in the stimulation of chick renal 25-hydroxyvitamin D3-1alpha-hydroxylase. (1978) (65)
Vitamin D endocrinology. (1976) (65)
Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. (1983) (65)
Circulating vitamin D metabolite concentrations in childhood renal diseases. (1982) (65)
5,6-Trans isomers of cholecalciferol and 25-hydroxycholecalciferol. Substitutes for 1,25-dihydroxycholecalciferol in anephric animals. (1972) (64)
Effect of Vitamin D Receptor Genotypes on Calcium Absorption, Duodenal Vitamin D Receptor Concentration, and Serum 1,25 Dihydroxyvitamin D Levels in Normal Women (1997) (64)
Response to Crystalline 1α-Hydroxyvitamin D3 in Vitamin D Dependency (1975) (64)
Binding proteins for vitamin D metabolites: serum carriers and intracellular receptors. (1981) (64)
Calcium-binding protein and calcium absorption after vitamin D administration. (1969) (64)
Metabolism of vitamin D2 and vitamin D3 in the rachitic chick (1967) (64)
Production of 1,25-dihydroxyvitamin D3 and formation of medullary bone in the egg-laying hen. (1979) (63)
Retinoic acid metabolism. (1979) (63)
Metabolism in vivo of all-trans-retinoic acid. Biosynthesis of 13-cis-retinoic acid and all-trans- and 13-cis-retinoyl glucuronides in the intestinal mucosa of the rat. (1982) (63)
Metabolism of 1,25-dihydroxycholecalciferol in the rat. (1972) (62)
Effect of vitamin A deficiency on intestinal cell proliferation in the rat. (1977) (62)
2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain. (2002) (62)
Molecular biology of vitamin D action. (1994) (62)
Citrate and action of vitamin D on calcium and phosphorus metabolism. (1963) (61)
Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20. (2000) (61)
Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain. (2000) (61)
Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation. (1984) (61)
1α,25-dihydroxyvitamin D3 a nd 19-nor-1α,25-dihydroxyvitamin 32 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo (1993) (60)
Cloning and characterization of the mouse vitamin D receptor promoter. (1997) (60)
Biological activity of 1,25-dihydroxyvitamin D2 in the chick. (1976) (60)
Placental transport of calcium and phosphorus is not regulated by vitamin D. (1984) (60)
Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression. (1992) (60)
Direct chemical synthesis of 1 alpha,25-dihydroxy[26,27-3H]vitamin D3 with high specific activity: its use in receptor studies. (1980) (60)
Id gene expression and its suppression by 1,25-dihydroxyvitamin D3 in rat osteoblastic osteosarcoma cells. (1992) (60)
A possible role of vitamin D receptors in regulating vitamin D activation in the kidney. (1995) (60)
Activation and fusion induced by 1 alpha,25-dihydroxyvitamin D3 and their relation in alveolar macrophages. (1984) (60)
Regulation of the procine 1,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 and parathyroid hormone in AOK-B50 cells. (2000) (59)
An equilibrium and kinetic study of 1,25-dihydroxyvitamin D3 binding to chicken intestinal cytosol employing high specific activity 1,25-dehydroxy[3H-26, 27] vitamin D3. (1979) (59)
Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism. (2008) (59)
Immunological identification of 1,25-dihydroxyvitamin D3 receptors in human promyelocytic leukemic cells (HL-60) during homologous regulation. (1989) (59)
Retinoic acid: some aspects of growth-promoting activity in the albino rat. (1968) (59)
Biological activity of 24,24-difluoro-1,25-dihydroxyvitamin D3. (1983) (58)
Identification of the Vitamin D Receptor in Osteoblasts and Chondrocytes But Not Osteoclasts in Mouse Bone (2014) (58)
Recent advances in the molecular biology of vitamin D action. (1996) (58)
Metabolites of dihydrotachysterol3 in target tissues. (1972) (58)
Mechanism and Function of High Vitamin D Receptor Levels in Genetic Hypercalciuric Stone‐Forming Rats (2004) (58)
Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. (1996) (58)
1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol. (1975) (58)
Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism. (1975) (58)
Inhibition of vitamin D metabolism by ethane-1-hydroxyl-1, 1-diphosphonate. (1974) (58)
Recent advances in the metabolism of vitamin D. (1981) (58)
Metabolism and biologica. (1976) (58)
Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor (2012) (58)
Chromatographic separation of mixtures of vitamin D2 , ergosterol, and tachysterol2. (1963) (57)
The Vitamin D Endocrine System and Its Therapeutic Potential (1996) (57)
Vitamin D metabolism. (1977) (57)
Metabolism and subcellular location of 25-hydroxycholecalciferol in intestinal mucosa. (1970) (57)
Bone resorption activity of all-trans retinoic acid is independent of vitamin D in rats. (2003) (57)
Calcium transport in small intestine during early development: role of vitamin D. (1980) (57)
THE NATURE OF CA++ BINDING BY KIDNEY MITOCHONDRIA. (1964) (57)
The Vitamin D Receptor—Structure and Transcriptional Activation (1997) (56)
Receptors of 1,25-dikydroxycholecalciferol in rat intestine. (1973) (56)
The mobilization of bone mineral by 1,25-dihydroxyvitamin D3 in hypophosphatemic rats. (1975) (56)
An in vivo study of the carrier proteins of 3H-vitamins D3 and D4 in rat serum. (1967) (56)
Formation of retinoic acid from retinol in the kidney. (1971) (55)
Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl. (2004) (55)
Bone resorbing activity of vitamin D metabolites and congeners in vitro: influence of hydroxyl substituents in the A ring. (1975) (55)
Metabolism of vitamin D3 in the chick embryo. (1974) (54)
Metaboism of 25-hydroxycholecalciferol in target and nontarget tissues. (1970) (54)
CD8+ T cells are not necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice (2002) (54)
William C. Rose lectureship in biochemistry and nutrition. Some new concepts emanating from a study of the metabolism and function of Vitamin D. (2009) (54)
Stimulation of lead absorption by vitamin D administration. (1978) (54)
High-pressure liquid chromatographic resolution of vitamin A compounds. (1978) (53)
1,25-Dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine. (2007) (53)
New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives. (2006) (53)
Metabolism of vitamin D3-3H in vitamin D-resistant rickets and familial hypophosphatemia. (1967) (53)
Localization of 1,25-dihydroxyvitamin D3 in intestinal nuclei in vivo. (1978) (53)
Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. (1980) (53)
Identification of 13-cis retinoic acid in tissue extracts and its biological activity in rats. (1967) (53)
The stimulation of 1,25-dihydroxycholecalciferol metabolism in vitamin D-deficient rats by 1,25-dihydroxycholecalciferol treatment. (1973) (52)
The chick intestinal cytosol binding protein for 1,25-dihydroxyvitamin D3: a study of analog binding. (1977) (52)
Effect of dietary calcium and phosphorus on intestinal calcium absorption and vitamin D metabolism. (1978) (52)
PARATHYROID HORMONE-DEPENDENT UPTAKE OF INORGANIC PHOSPHATE BY MITOCHONDRIA. (1963) (51)
Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo. (1990) (51)
Retinol in addition to retinoic acid is required for successful gestation in vitamin A-deficient rats. (1995) (51)
Induction of calbindin-D 9k mRNA but not calcium transport in rat intestine by 1,25-dihydroxyvitamin D3 24-homologs. (1991) (51)
The 26-hydroxylation of 25-hydroxyvitamin D3 in vitro by chick renal homogenates. (1978) (51)
Comparative studies on the 25-hydroxylation of vitamin D 3 and dihydrotachysterol 3 . (1973) (51)
Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat. (1984) (51)
Identification of the vitamin D receptor in various cells of the mouse kidney (2012) (51)
Reproductive defects are corrected in vitamin d-deficient female rats fed a high calcium, phosphorus and lactose diet. (2002) (51)
Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor. (1996) (50)
Identification of the porcine intestinal 1,25-dihydroxyvitamin D3 receptor on sodium dodecyl sulfate/polyacrylamide gels by renaturation and immunoblotting. (1985) (50)
THE CONTROL OF CALCIUM AND PHOSPHORUS METABOLISM BY THE VITAMIN D ENDOCRINE SYSTEM* (1980) (50)
Calcium Control of the In Vivo Biosynthesis of 1,25 Dihydroxyvitamin D 3 : Nicolaysen's Endogenous Factor (1972) (50)
24,25-Dihydroxyvitamin D3. Synthesis and biological activity. (1973) (50)
Characterization of intestinal phosphate absorption using a novel in vivo method. (2007) (50)
Studies on the site of 1,25-dihydroxyvitamin D3 synthesis in vivo. (1983) (50)
All-trans retinoic acid antagonizes the action of calciferol and its active metabolite, 1,25-dihydroxycholecalciferol, in rats. (2005) (50)
Subcellular location of vitamin D and its metabolites in intestinal mucosa after a 10-IU dose. (1967) (50)
Potential use of 1,25-dihydroxycholecalciferol for prevention of parturient paresis. (1979) (49)
Rickets of prematurity. Supranormal levels of serum 1,25-dihydroxyvitamin D. (1981) (49)
Mechanism of 25-hydroxycholecalciferol 1 -hydroxylation. Incorporation of oxygen-18 into the 1 position of 25-hydroxycholecalciferol. (1973) (49)
The Wilms' Tumor Gene Product (WT1) Modulates the Response to 1,25-Dihydroxyvitamin D3 by Induction of the Vitamin D Receptor* (2001) (49)
A bioassay capable of measuring 1 picogram of 1,25-dihydroxyvitamin D3. (1978) (49)
Metabolites of all-trans-retinoic acid in bile: identification of all-trans- and 13-cis-retinoyl glucuronides. (1982) (48)
Combinational effects of vitamin D3 and retinoic acid (all trans and 9 cis) on proliferation, differentiation, and programmed cell death in two small cell lung carcinoma cell lines. (1998) (48)
Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats (1983) (48)
Thyrotropes in the pituitary are target cells for 1,25 dihydroxy vitamin D3 (2004) (47)
Role of 1,25-dihydroxycholecalciferol in calcification of bone and maintenance of serum calcium concentration in the rat. (1972) (47)
Analysis of binding of the 1,25-dihydroxyvitamin D3 receptor to positive and negative vitamin D response elements. (1996) (47)
Vitamin D deficiency diminishes the severity and delays onset of experimental autoimmune encephalomyelitis. (2011) (47)
The regulation of calciferol-25-hydroxylase in the chick. (1974) (47)
1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization. (2005) (47)
5,6-Trans-25-Hydroxycholecalciferol: Vitamin D Analog Effective on Intestine of Anephric Rats (1972) (47)
Vitamin D stimulation of [3H]orotic acid incorporation into ribonucleic acid of rat intestinal mucosa. (1967) (47)
Action of 1,25-dihydroxyvitamin D3 and a diphosphonate on calcium metabolism in rats. (1975) (46)
A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation. (2002) (46)
1,25-Dihydroxyvitamin D3 stimulated increase of 7,8-didehydrocholesterol levels in rat skin. (1980) (46)
Effect of lead ingestion on functions of vitamin D and its metabolites. (1981) (46)
Phosphorylation is involved in transcriptional activation by the 1,25-dihydroxyvitamin D3 receptor. (1993) (46)
Synthesis and biological activity of 2-hydroxy and 2-alkoxy analogs of 1 alpha,25-dihydroxy-19-norvitamin D3. (1994) (46)
Isolation of an inhibitor of 25-hydroxyvitamin D3-1-hydroxylase from rat serum. (1976) (46)
The effect of 1,25(OH)2 vitamin D3 supplementation in premature infants. (1978) (46)
Synthesis and biological activity of 25,26-dihydroxycholecalciferol (1975) (46)
Measurement of mammalian 25-hydroxyvitamin D3 24R-and 1 alpha-hydroxylase. (1981) (45)
Calcitonin inhibition of vitamin D-induced intestinal calcium absorption. (1972) (45)
Adequate response of plasma 1,25-dihydroxyvitamin D to parturition in paretic (milk fever) dairy cows. (1977) (45)
Lactose facilitates the intestinal absorption of lead in weanling rats. (1981) (45)
Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D. (1981) (45)
A highly sensitive method for large-scale measurements of 1,25-dihydroxyvitamin D. (1998) (45)
X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydroxycholecalciferol. (1973) (44)
Vitamin D metabolites and bioactive parathyroid hormone levels during Spacelab 2. (1988) (44)
New Concepts of Vitamin D Functions a (1992) (44)
Structure and nucleotide sequence of the rat intestinal vitamin D-dependent calcium binding protein gene. (1988) (44)
Vitamin D as immunomodulatory therapy for kidney transplantation. (2002) (44)
The effect of inhibitors of protein and RNA synthesis on 1 alpha,25-dihydroxyvitamin D3-dependent calcium uptake in cultured embryonic chick duodenum. (1981) (44)
Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. (1994) (44)
The kidney as an endocrine organ involved in calcium homeostasis. (1973) (43)
Vitamin D. Metabolism and mechanism of action. (1973) (43)
Relationship of 25-hydroxyvitamin D3 side chain structure to biological activity. (1975) (43)
Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene. (1992) (43)
Interaction between vitamin D receptor and vitamin D ligands: two-dimensional alanine scanning mutational analysis. (2003) (43)
The relationship between the vitamin D system and cancer. (1986) (43)
Characterization of a specific, high affinity binding macromolecule for 1 alpha, 25-dihydroxyvitamin D3 in cultured chick kidney cells. (1980) (43)
Side chain metabolism of 25-hydroxy-[26,27-14C] vitamin D3 and 1,25-dihydroxy-[26,27-14C] vitamin D3 in vivo. (1976) (43)
The regulation of 24,25-dihydroxyvitamin D3 production in cultures of monkey kidney cells. (1977) (43)
The vitamin D—induced differentiation of HL-60 cells: Structural requirements (1987) (43)
25-Hydroxyvitamin D3-1-hydroxylase. Inhibition in vitro by rat and pig tissues. (1974) (42)
Subcellular location and properties of rat renal 25-hydroxyvitamin D3-1 alpha-hydroxylase. (1985) (42)
Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60. (1987) (42)
Solanum glaucophyllum as source of 1,25-dihydroxyvitamin D3. (1977) (42)
1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children. (1977) (42)
VITAMIN D AND PHOSPHOLIPID METABOLISM. (1964) (42)
An in vitro study of vitamin D2 hydroxylases in the chick. (1976) (42)
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure. (2008) (42)
Mechanism of action of superactive vitamin D analogs through regulated receptor degradation (2000) (42)
Origin of 25-hydroxyvitamin D3 binding protein from tissue cytosol preparations. (1979) (42)
Selective Binding Properties of Vitamin D Transport Protein in Chick Plasma in vitro (1974) (41)
Biological activity of 1?-hydroxyvitamin D in the rat (1975) (41)
Formation of 1,24-24-trihydroxyvitamin D3 from 1,25-dihydroxyvitamin D3 (1974) (41)
Metabolism of retinoic acid in vitamin A-deficient rats (1974) (41)
Serum 25-hydroxyvitamin D concentrations of free-living subjects consuming olestra. (1991) (41)
Plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels in paretic dairy cows. (1978) (41)
Vitamin D--resistant rickets: end-organ unresponsiveness to 1,25(OH)2D3. (1980) (41)
A New Vitamin D Analog, 2MD, Restores Trabecular and Cortical Bone Mass and Strength in Ovariectomized Rats With Established Osteopenia (2005) (41)
Ligand-specific structural changes in the vitamin D receptor in solution. (2011) (41)
Vitamin D metabolite concentrations in vitamin D deficiency. Are calcitriol levels normal. (1981) (41)
Parathyroid hormone as a trophic hormone for 1,25-dihydroxyvitamin D3, the metabolically active form of vitamin D. (1972) (41)
The effect of vitamin D3 metabolites on membrane proteins of chick duodenal brush borders. (1976) (40)
Molecular cloning of the cDNA and chromosomal gene for vitamin D-dependent calcium-binding protein of rat intestine. (1987) (40)
Parathyroid hormone decreases renal vitamin D receptor expression in vivo. (2005) (40)
Cloning and origin of the two forms of chicken vitamin D receptor. (1997) (40)
The avian vitamin D receptors: primary structures and their origins. (1994) (40)
24-hydroxylation of 25-hydroxyvitamin D3: is it required for embryonic development in chicks? (1982) (40)
An examination of the importance of 24-hydroxylation to the function of vitamin D during early development. (1981) (40)
Purification of human serum vitamin D-binding protein by 25-hydroxyvitamin D3-Sepharose chromatography. (1986) (39)
Solid-state conformations of vitamin D3. (1976) (39)
Isolation and identification of 23,25-dihydroxyvitamin D3, an in vivo metabolite of vitamin D3. (1981) (39)
1α-Hydroxyvitamin D2: A Potent Synthetic Analog of Vitamin D2 (1974) (38)
Suppression of experimental autoimmune encephalomyelitis by 300-315nm ultraviolet light. (2013) (38)
Identification of the porcine intestinal accessory factor that enables DNA sequence recognition by vitamin D receptor. (1995) (38)
Isolation and identification of 24-hydroxyvitamin D2 and 24,25-dihydroxyvitamin D2. (1980) (38)
1,25,26-trihydroxyvitamin D3: isolation, identification, and biological activity. (1981) (38)
Vitamin D-influenced gene expression via a ligand-independent, receptor-DNA complex intermediate. (1993) (38)
Novel convergent synthesis of side-chain-modified analogs of 1.alpha.,25-dihydroxycholecalciferol and 1.alpha.,25-dihydroxyergocalciferol (1988) (37)
24,24-difluoro-1,25-dihydroxyvitamin D3: in vitro production, isolation, and biological activity. (1980) (37)
Nuclear receptor 4A2 and C/EBPβ regulate the parathyroid hormone-mediated transcriptional regulation of the 25-hydroxyvitamin D3-1α-hydroxylase (2007) (37)
Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. (1996) (37)
1,25-dihydroxyvitamin D3-treated hypoparathyroidism: 35 patients years in 10 children. (1982) (37)
Resolution and reconstitution of soluble components of rat liver microsomal vitamin D3-25-hydroxylase. (1980) (37)
Essential fatty acids and ionic permeability of lecithin membranes (1969) (37)
25-Hydroxycholecalciferol, the probable metabolically active form of vitamin D. Isolation, identification, and subcellular location. (1969) (37)
Induction of calcium-binding protein before 1,25-dihydroxyvitamin D3 stimulation of duodenal calcium uptake. (1983) (36)
Characterization of human androgen receptor overexpressed in the baculovirus system. (1992) (36)
Activity of various hydroxylated vitamin D3 analogs for improving phosphorus utilisation in chicks receiving diets adequate in vitamin D3. (1998) (36)
VITAMIN D-STIMULATED RELEASE OF CALCIUM FROM MITOCHONDRIA. (1964) (36)
Characteristics of the 25-hydroxyvitamin D3- and 1,25-dihydroxyvitamin D3-24-hydroxylase(s) from HL-60 cells. (1991) (36)
23,25-Dihydroxyvitamin D3: a natural precursor in the biosynthesis of 25-hydroxyvitamin D3-26,23-lactone. (1981) (36)
The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. (2002) (36)
Role of vitamin D in maternal skeletal changes during pregnancy and lactation: A histomorphometric study (1982) (36)
Importance of the stereochemical position of the 24-hydroxyl to biological activity of 24-hydroxyvitamin D3. (1975) (36)
1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates. (2012) (36)
Lack of effect of calcitonin on the regulation of vitamin D metabolism in the rat. (1977) (36)
1-Fluorovitamin D3, a vitamin D3 analogue more active on bone-calcium mobilization than on intestinal-calcium transport. (1979) (36)
Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation. (1997) (35)
Metabolism and molecular mechanism of action of vitamin D: 1981. (1982) (35)
Renal tubular acidosis does not alter circulating values of calcitriol. (1984) (35)
Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3. (1983) (35)
Metabolism of a physiological amount of all-trans-retinol in the vitamin A-deficient rat. (2001) (35)
25-hydroxydihydrotachysterol. Synthesis and biological activity. (1970) (35)
Synthesis and biological activity of vitamin D3-sulfate. (1981) (35)
Bone resorbing activities of 24-hydroxy stereoisomers of 24-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. (1975) (34)
Vitamin A and ribonucleic acid synthesis in rat intestine. (1970) (34)
Purification of chicken intestinal receptor for 1 alpha, 25-dihydroxyvitamin D3 to apparent homogeneity. (1982) (34)
STRUCTURAL CHANGES IN ISOLATED LIVER MITOCHONDRIA OF RATS DURING ESSENTIAL FATTY ACID DEFICIENCY (1964) (34)
The role of vitamin D and its relationship to parathyroid hormone and calcitonin. (1971) (34)
Intestinal calcium transport: parathyroid hormone and adaptation to dietary calcium. (1976) (34)
1 alpha-hydroxy-25-fluorovitamin D3: a potent analogue of 1 alpha,25-dihydroxyvitamin D3. (1978) (34)
Review article: Vitamin D metabolism during pregnancy (1986) (33)
Impact of prepartum dietary phosphorus intake on calcium homeostasis at parturition. (1987) (33)
On the physiological basis of vitamin A-stimulated growth. (1979) (33)
Antirachitic Activity of 1α-Hydroxyergocalciferol and 1α-Hydroxycholecalciferol in Rats (1984) (33)
Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells. (1995) (33)
Lack of effect of vitamin D and its metabolites on intestinal phosphate transport in familial hypophosphatemia of mice. (1977) (33)
A specific 1,25-dihydroxyvitamin D3 binding macromolecule in chicken bone. (1980) (33)
Mechanism of 25-hydroxyvitamin D3 24-hydroxylation: incorporation of oxygen-18 into the 24 position of 25-hydroxyvitamin D3. (1977) (33)
Evidence for a defect in the formation of 1alpha,25-dihydroxyvitamin D in pseudohypoparathyroidism. (1977) (33)
Treatment of renal osteodystrophy with 25-hydroxycholecalciferol. (1970) (33)
Purification and properties of chick renal mitochondrial ferredoxin. (1980) (33)
Synthesis of (6-3H)-1alpha-hydroxyvitamin D3 and its metabolism in vivo to (3H)-1alpha,25-dihydroxyvitamin D3 (1975) (33)
Overproduction of rat 1,25-dihydroxyvitamin D3 receptor in insect cells using the baculovirus expression system. (1991) (32)
Sites of phosphorylation and photoaffinity labeling of the 1,25-dihydroxyvitamin D3 receptor. (1991) (32)
Determination of vitamin D and its metabolites in plasma. (1980) (32)
Metabolism of tritiated vitamin D3 in familial vitamin D-resistant rickets with hypophosphatemia. (1967) (32)
Incorporation of retinoic acid into proteins via retinoyl-CoA. (1989) (32)
A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D. (1978) (32)
Autoradiographic localization of target cells for 1α, 25-dihydroxyvitamin D3 in bones from fetal rats (2006) (32)
Characterization of retinoyl beta-glucuronide as a minor metabolite of retinoic acid in bile. (1980) (32)
A new member to the astacin family of metalloendopeptidases: a novel 1,25-dihydroxyvitamin D-3-stimulated mRNA from chorioallantoic membrane of quail. (1994) (32)
Effects of 25-hydroxycholecalciferol in patients with familial hypophosphatemia and vitamin-D-resistant rickets. (1970) (32)
Biliary metabolites of all-trans-retinoic acid in the rat: isolation and identification of a novel polar metabolite. (1982) (32)
25-hydroxyergocalciferol: a biologically active metabolite of vitamin D2. (1969) (31)
The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1‐year phase 2 double‐blind, placebo‐controlled, randomized clinical trial (2011) (31)
Possible precursor of vitamin D stimulated calcium binding protein in rats. (1971) (31)
Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol. (1976) (31)
Islet Insulin Release and Net Calcium Retention In Vitro in Vitamin D–Deficient Rats (1986) (31)
Synthesis of 25-hydroxy[26,27-3h]vitamin D3 with high specific activity. (1979) (31)
On the site of discrimination of chicks against vitamin D. (1969) (31)
Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3). (2007) (31)
VITAMIN D AND CALCIUM TRANSPORT * (1978) (31)
Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin (2009) (31)
The biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. (1968) (31)
Alterations in mRNA expression of duodenal 1,25-dihydroxyvitamin D3 receptor and vitamin D-dependent calcium binding protein in aged wistar rats (1994) (30)
Metabolism of 1alpha-hydroxyvitamin D3 in the chick. (1976) (30)
Autoradiographic demonstration of target cells for 1,25-dihydroxycholecalciferol in the chick embryo chorioallantoic membrane, duodenum, and parathyroid glands. (1980) (30)
Direct C-1 hydroxylation of vitamin D compounds: convenient preparation of 1alpha-hydroxyvitamin D3, 1alpha, 25-dihydroxyvitamin D3, and 1alpha-hydroxyvitamin D2. (1978) (30)
The mouse vitamin D receptor is mainly expressed through an Sp1-driven promoter in vivo. (2000) (30)
25-Azavitamin D3, an inhibitor of vitamin D metabolism and action. (1979) (30)
Pathways of retinoic acid and retinol metabolism. (1969) (30)
Stereoselective syntheses of (22R)- and (22S)-22-methyl-1.alpha.,25-dihydroxyvitamin D3: active vitamin D3 analogs with restricted side-chain conformation (1993) (30)
Moderate cholecalciferol supplementation depresses intestinal calcium absorption in growing dogs. (2002) (30)
Efficacy and safety of 1alpha-hydroxyvitamin D3 for prevention of parturient paresis. (1977) (30)
The transformation of a vitamin into a hormone: the vitamin D story. (1979) (29)
Influence of Long-Term Oral 1,25-Dihydroxyvitamin D in Childhood Renal Osteodystrophy1 (1980) (29)
Isolation of a mRNA that encodes a putative intestinal alkaline phosphatase regulated by 1,25-dihydroxyvitamin D-3. (1991) (29)
1,25-Dihydroxyvitamin D3-stimulated mRNAs in rat small intestine. (1986) (29)
Synthesis and biological activity of 3-deoxy-1α-hydroxyvitamin D3+† (1974) (29)
Autoradiographic localization of 1,25-dihydroxyvitamin D3 in rat placenta and yolk sac. (1983) (29)
Role of kidney tissue in the production of 25-hydroxyvitamin D3-26,23-lactone and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone. (1980) (29)
New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro. (2007) (29)
Stabilization of 1,25-dihydroxyvitamin D-3 receptor in the human leukemia cell line, HL-60, with diisopropylfluorophosphate. (1989) (29)
Metabolites of 1 alpha, 25-dihydroxyvitamin D3 in rat bile. (1980) (29)
DNA labeling of rat epithelial tissues in vitamin A deficiency. (1981) (29)
2MD, a new anabolic agent for osteoporosis treatment (2006) (29)
Historical Overview of Vitamin D (2011) (29)
Formation of vitamin D esters in vivo (1967) (29)
1 Vitamin D: Revisited 1980 (1980) (29)
Effects of 1,24 dihydroxyvitamin D3 and calcitonin on fracture healing in adult rats. (1981) (29)
1,25-Dihydroxyvitamin D3 metabolism. The effect of dietary calcium and phosphorus. (1978) (28)
1,25-Dihydroxyvitamin D3 receptors in human carcinomas: a pilot study. (1991) (28)
New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations. (2007) (28)
25-Hydroxycholecalciferol: a biologically active metabolite of cholecalciferol (1968) (28)
CALCIUM EXCHANGE IN ISOLATED INTESTINAL VILLI. (1963) (28)
Solubilization and reconstitution of chick renal mitochondrial 25-hydroxyvitamin D3 24-hydroxylase. (1986) (28)
Vitamin D and the parenteral nutrition patient. (2009) (28)
Action of Solanum malacoxylon on calcium metabolism in the rat. (1974) (28)
Isolation and identification of 25-hydroxycholecalciferol from human plasma. (1972) (28)
Metabolism of 1alpha,25-dihydroxyvitamin D(3) in vitamin D receptor-ablated mice in vivo. (2000) (28)
Purification of the receptor for 1 alpha,25-dihydroxyvitamin D3 from chicken intestine. (1983) (27)
Regulation of renal vitamin D receptor is an important determinant of 1alpha,25-dihydroxyvitamin D(3) levels in vivo. (2002) (27)
An immunoradiometric assay for 1,25-dihydroxyvitamin D3 receptor. (1989) (27)
Growth Velocity in a Child on Prolonged Hemodialysis: Beneficial Effect of 1-α-Hydroxyvitamin D3 (1977) (27)
Kinetic properties of 25-hydroxyvitamin D- and 1,25-dihydroxyvitamin D-24-hydroxylase from chick kidney. (1991) (27)
Recent advances in the metabolism and function of vitamin D. (1969) (27)
The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃. (2015) (27)
A new vaginal smear assay for vitamin A in rats. (1982) (27)
How should the recommended dietary allowances be revised? A concept paper from the Food and Nutrition Board (1994) (27)
The role of vitamin D in chorioallantoic membrane calcium transport. (1994) (27)
Aggregation properties of the 1,25-dihydroxyvitamin D3 receptor from chick intestinal cytosol. (1979) (27)
Synthesis of vitamin D5: its biological activity relative to vitamins D3 and D2. (1979) (27)
A novel, fully-automated, chemiluminescent assay for the detection of 1,25-dihydroxyvitamin D in biological samples (2016) (26)
Safety assessment of the post-harvest treatment of button mushrooms (Agaricus bisporus) using ultraviolet light. (2013) (26)
Parathyroid hormone stimulation of phosphate uptake by rat liver mitochondria. (1963) (26)
25-Hydroxycholecalciferol (25-OHD3). II. Efficacy of parenteral administration in prevention of parturient paresis. (1973) (26)
Synthesis of 24S and 24R-hydroxy-[24-3H]vitamin D3 and their metabolism in rachitic rats. (1976) (26)
Vitamin D3-stimulated template activity of chromatin from rat intestine. (1969) (26)
Hypercalcemia produced by parathyroid hormone suppresses experimental autoimmune encephalomyelitis in female but not male mice. (2005) (26)
Vitamin D endocrine system. (1977) (25)
Incorportion of oxygen-18 into the 25-position of cholecalciferol by hepatic cholecalciferol 25-hydroxylase. (1978) (25)
Biosynthesis of retinoyl-β-glucuronide, a biologically active metabolite of all-trans-retinoic acid (1986) (25)
Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models. (2011) (25)
Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: correction by glucocorticoid therapy. (1981) (25)
DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3. (1989) (25)
The biological activity of retinotaurine. (1982) (25)
A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene. (1994) (25)
Rat plasma 25-hydroxyvitamin D3 binding protein: an inhibitor of the 25-hydroxyvitamin D3-1alpha-hydroxylase. (1978) (25)
Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid. (1978) (25)
Retinol is specifically required during midgestation for neonatal survival. (1997) (25)
Biliary metabolites of all-trans-retinoic acid in the rat. (1983) (25)
RECENT ADVANCES IN OUR UNDERSTANDING OF THE METABOLISM OF VITAMIN D AND ITS REGULATION (1976) (25)
Isolation and identification of 25-hydroxyvitamin D2 25-glucuronide: a biliary metabolite of vitamin D2 in the chick. (1981) (25)
Osteoporosis and the metabolites of vitamin D. (1990) (24)
Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1 alpha-hydroxylase. (1997) (24)
Functional interference between AP-1 and the vitamin D receptor on osteocalcin gene expression in human osteosarcoma cells. (1994) (24)
Vitamin D and the structure of kidney mitochondria. (1960) (24)
A biologically active metabolite of retinoic acid from rat liver. (1965) (24)
Metabolism of 25-hydroxyvitamin D3 by rat kidney cells in culture: isolation and identification of cis- and trans-19-nor-10-oxo-25-hydroxyvitamin D3. (1984) (24)
1- but not 24-hydroxylation of vitamin D is required for skeletal mineralization in rats. (1983) (24)
An enzyme‐linked immunoassay for the 1,25‐dihydroxyvitamin D3 receptor protein (1996) (24)
Vitamin D: a new look at an old vitamin. (2009) (24)
Synthesis and biological activity of 1 alpha-fluoro-25-hydroxyvitamin D3. (1984) (24)
Inhibition of the metabolism of 25-hydroxycholecalciferol by actinomycin D and cycloheximide. (1971) (24)
Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis. (1985) (24)
5,6-epoxyretinoic acid is a physiological metabolite of retinoic acid in the rat. (1980) (24)
Identification of 5,8-oxyretinoic acid isolated from small intestine of vitamin A-deficient rats dosed with retinoic acid. (1978) (23)
23,24,25-Trihydroxyvitamin D3, 24,25,26-trihydroxyvitamin D3, 24-keto-25-hydroxyvitamin D3, and 23-dehydro-25-hydroxyvitamin D3: new in vivo metabolites of vitamin D3. (1981) (23)
The necessity for calcium for increased renal vitamin D receptor in response to 1,25-dihydroxyvitamin D. (1993) (23)
Molecular events involved in 1,25-dihydroxyvitamin D3 stimulation of intestinal calcium transport. (1982) (23)
The effects of lactose on the absorption and retention of dietary lead. (1983) (23)
Bone mineral loss during lactation occurs in absence of parathyroid tissue. (1992) (23)
Renal-nonresponsive, bone-responsive pseudohypoparathyroidism. A case with normal vitamin D metabolite levels and clinical features of rickets. (1984) (23)
THE SUBCELLULAR LOCATION OF H3 VITAMIN D3 IN KIDNEY AND INTESTINE. (1964) (23)
Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA. (1997) (23)
Impaired homologous upregulation of vitamin D receptor in rats with chronic renal failure. (1994) (23)
Water-soluble vitamin D in human milk: a myth. (1982) (23)
Vitamin D and the incorporation of [1-14C]acetate into the organic acids of bone. (1964) (23)
Synthesis of 25-hydroxy[23,24-3H]vitamin D3. (1978) (23)
Successful treatment of genetically hypophosphatemic mice by 1 alpha-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3. (1980) (23)
22 Marabou Symposium: the changing faces of vitamin D. (2008) (22)
Chapter 18. Vitamin D: Metabolism and Mechanism of Action (1984) (22)
Synthesis and biological activity of 24-hydroxy-25-fluorovitamin D3. A highly potent mediator of calcium metabolism. (1979) (22)
An in vitro study of the stability of the chicken intestinal cytosol 1,25-dihydroxyvitamin D3-specific receptor. (1980) (22)
Renal 25-hydroxyvitamin D3-1-hydroxylase in patients with renal disease. (1988) (22)
Studies on the role of 1,25-dihydroxyvitamin D in chick embryonic development. (1986) (22)
CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. (2002) (22)
UV light selectively inhibits spinal cord inflammation and demyelination in experimental autoimmune encephalomyelitis. (2015) (22)
Natural 25,26-dihydroxyvitamin D3 is an epimeric mixture. (1983) (22)
High-pressure liquid chromatography of vitamin D metabolites and analogs. (1980) (22)
Characterization of 1,25-dihydroxyvitamin D3-dependent calcium uptake in cultured embryonic chick duodenum. (1981) (22)
Production of 10-oxo-19-nor-25-hydroxyvitamin D3 by solubilized kidney mitochondria from chick and rat. (1985) (22)
On the subcellular location of vitamin D metabolites in intestine. (1970) (22)
Role of parathyroid hormone and 1,25-dihydroxyvitamin D3 in the development of osteopenia in oophorectomized rats (1982) (22)
1,25-Dihydroxyvitamin D3 target cells in rat mammary gland. (1981) (21)
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase (2012) (21)
Glucocorticoids and appearance of 1,25-dihydroxyvitamin D3 receptor in rat intestine. (1983) (21)
Side chain oxidation of 25-hydroxy-[26,27-14C]vitamin D3 and 1,25-dihydroxy-[26,27-14C]vitamin D3 in vivo by chickens. (1976) (21)
Relationship between vitamin D deficiency, thyrocalcitonin, and parathyroid hormone. (1967) (21)
Synthesis of 25-hydroxyvitamin D2 and its 24-epimer (1984) (21)
Role of the hypophysis in the regulation of vitamin D metabolism (1981) (21)
1 alpha, 25-Dihydroxyvitamin D3 and 19-nor-1 alpha, 25-dihydroxyvitamin D2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo. (1993) (21)
Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity. (2009) (21)
Retinoic acid 5,6-epoxidase. Properties and biological significance. (1982) (21)
Intestinal calcium and phosphate transport in genetic hypophosphatemic mice. (1976) (21)
1- but not 24-hydroxylation of vitamin D is required for growth and reproduction in rats. (1983) (21)
Metabolism of retinoic acid in vivo in the vitamin A-deficient rat. (1982) (21)
The absolute configuration of the natural 25,26‐dihydroxycholecalciferol (1978) (21)
Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2. (1988) (20)
Screening of selective inhibitors of 1α,25-dihydroxyvitamin D3 24-hydroxylase using recombinant human enzyme expressed in Escherichia coli. (2010) (20)
1 alpha-hydroxycholecalciferol in hemodialysis renal osteodystrophy. Adverse effects of anticonvulsant therapy. (1976) (20)
Essential fatty acid deficiency and rat liver homogenate oxidations. (1963) (20)
The metabolism and function of vitamin D. (1971) (20)
Vitamin D-deficient rats produce reduced quantities of a nutritionally adequate milk. (1984) (20)
Support of embryonic chick survival by vitamin D metabolites. (1983) (20)
1α-Hydroxy-19-nor-vitamin D C-22 aldehyde. A valuable intermediate in the synthesis of side chain modifed 1α,25-dihydroxy-19-nor-vitamin D3 (1992) (20)
Stimulation of specific 1,25-dihydroxyvitamin D3 binding protein in cultured postnatal rat intestine by hydrocortisone. (1982) (20)
ACTION OF VITAMIN A ON LIVER HOMOGENATE OXIDATION OF TRICARBOXYLIC ACID CYCLE INTERMEDIATES. (1963) (20)
Immunopurified 25-hydroxyvitamin D 1 alpha-hydroxylase and 1,25-dihydroxyvitamin D 24-hydroxylase are closely related but distinct enzymes. (1992) (20)
1,25-Dihydroxyvitamin C3-stimulated active uptake of phosphate by rat jejunum. (1982) (20)
Effect of vitamin D deficiency on in vitro labeling of chick intestinal proteins: analysis by two-dimensional electrophoresis. (1981) (20)
25-Hydroxydihydrotachysterol3 BIOSYNTHESIS IN VIVO AND IN VITRO (1971) (20)
Stimulation of (3H)uridine incorporation into nuclear RNA of rat kidney by vitamin D metabolites. (1973) (20)
The influence of parathyroid hormone upon glutamate oxidation in isolated mitochondria (1963) (20)
Novel synthesis of 2-substituted 19-norvitamin D A-ring phosphine oxide from D-glucose as a building block. (2003) (20)
Pediatric diseases related to calcium (1980) (19)
Self-selection of a high calcium diet by vitamin D-deficient lactating rats increases food consumption and milk production. (1984) (19)
Three-dimensional structure-function relationship of vitamin D: side chain location and various activities. (1999) (19)
1H nuclear magnetic resonance studies of the conformations of vitamin D compounds in various solvents. (1985) (19)
Identification of a transcription factor that binds to the promoter region of the human parathyroid hormone gene. (1999) (19)
Oxidative decarboxylation of retinoic acid in microsomes of rat liver and kidney. (1968) (19)
25-hydroxydihydrotachysterol 3 -stimulation of bone resorption in tissue culture. (1971) (19)
Effects of retinoic acid (all-trans and 9-cis) on tumor progression in small-cell lung carcinoma. (1998) (19)
Renal mitochondrial ferredoxin active in 25-hydroxyvitamin D3 1 alpha-hydroxylase. Characterization of the iron-sulfur cluster using interprotein cluster transfer and electron paramagnetic resonance spectroscopy. (1980) (19)
Effectiveness of 1 alpha-hydroxyvitamin D3 in children with renal osteodystrophy associated with hemodialysis. (1977) (19)
Design, Synthesis, and Biological Evaluation of a 1α,25-Dihydroxy-19-norvitamin D3 Analogue with a Frozen A-Ring Conformation (2007) (19)
Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones--weak agonists. (2008) (19)
Dependence of 25-hydroxycholecalciferol-1-hydroxylase regulation on RNA and protein synthesis. (1972) (19)
Dietary 135-fold cholecalciferol supplementation severely disturbs the endochondral ossification in growing dogs. (2003) (19)
Effect of 1,25-dihydroxyvitamin D3 on osteopenia induced by prednisolone in adult rats (1982) (19)
Biological activities and binding properties of 23,23-difluoro-25-hydroxyvitamin D3 and its 1α-hydroxy derivative (1985) (18)
A single receptor identical with that from intestine/T47D cells mediates the action of 1,25-dihydroxyvitamin D-3 in HL-60 cells. (1992) (18)
Identification of a unique subset of 2-methylene-19-nor analogs of vitamin D with comedolytic activity in the rhino mouse. (2010) (18)
Immunoreactivity of Six Monoclonal Antibodies Directed Against 1,25-dihydroxyvitamin-D3 Receptors in Human Skin (2000) (18)
Effect of estrogen therapy on calcium absorption and vitamin D metabolism in postmenopausal osteoporosis (1978) (18)
Concentration of calcium, phosphorus, and 1,25-dihydroxyvitamin D in plasma of dairy cows during the lactation cycle. (1981) (18)
Current concepts. Vitamin D. (1969) (18)
Model of three‐dimensional structure of vitamin D receptor and its binding mechanism with 1α,25‐dihydroxyvitamin D3 (2001) (18)
Oxygen-dependent 1,25-dihydroxycholecalciferol-induced calcium ion transport in rat intestine. (1981) (18)
Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol. (1970) (18)
Mediation of calcium adaptation by 1,25-dihydroxycholecalciferol. (1977) (18)
Synthesis of 1α,25-dihydroxyvitamin D2, its 24 epimer and related isomers, and their binding affinity for the 1,25-dihydroxyvitamin D3 receptor (1985) (18)
25-Hydroxycholecalciferol (25-OHD3). I. Treatment for parturient paresis. (1973) (18)
Sertoli cells in the testis and epithelium of the ductuli efferentes are targets for 3H 1,25 (OH)2 vitamin D3 (1987) (18)
Effects of 1.25 Dihydroxyvitamin D3 and Calcitonin on Fracture Healing in Adult Rats (1981) (17)
Selective analogs of 1α,25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D (2007) (17)
Vitamin D: the discovery of its metabolites and their therapeutic applications. (1976) (17)
Unique rearrangement of ergocalciferol side chain in vitro: production of a biologically highly active homologue of 1,25-dihydroxyvitamin D3. (1986) (17)
Function of the fat-soluble vitamins. (1975) (17)
Stimulation of 1,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3 in the hypocalcaemic rat. (1983) (17)
The vitamin d hormonal system: implications for bone diseases. (1980) (17)
Inhibition of 25-hydroxyvitamin D3 production by 1, 25-dihydroxyvitamin D3 in rats. (1998) (17)
Effect of vitamin D3 metabolites on calcium and phosphorus metabolism in chick embryos. (1985) (17)
A specific binding protein for 1,25-dihydroxyvitamin D3 in rat intestinal cytosol. (1977) (17)
Crystal structure of 25-hydroxy-vitamin D3 monohydrate: a stereochemical analysis of vitamin D molecules (1977) (17)
Partial amino acid sequence of porcine 1,25-dihydroxyvitamin D3 receptor isolated by immunoaffinity chromatography. (1988) (17)
Studies on the relation of DNA synthesis to retinoic acid-induced differentiation of F9 teratocarcinoma cells. (1986) (17)
Side chain oxidation of 1, 25-dihydroxyvitamin D3 in the rat: effect of removal of the intestine. (1977) (17)
The importance of stereochemistry on the actions of vitamin D. (2011) (17)
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1a-hydroxylase gene promoter (vitamin Dycalciumyboneykidneyycyclic AMP) (1998) (17)
NMR assignments of tryptophan residue in apo and holo LBD‐rVDR (2005) (17)
Determination of biological activity of 24,24-difluoro-1,25-dihydroxyvitamin D3 in the chick using a new method for assessing intestinal calcium uptake. (1982) (17)
The adrenal: A new target organ of the calciotropic hormone 1,25-dihydroxyvitamin D3 (2004) (17)
Metabolism of 25-hydroxycholecalciferol and its inhibition by actinomycin D and cycloheximide. (1971) (17)
1 alpha-Hydroxyvitamin D2 is less toxic than 1 alpha-hydroxyvitamin D3 in the rat. (1985) (17)
25-hydroxycholecalciferol. The probable metabolically active form of vitamin D3: its identification and subcellular site of action. (1969) (17)
Role of kidney tissue in metabolism of vitamin D. (1971) (17)
Synthesis and biological activity of 1 alpha, 25-dihydroxy-18-norvitamin D3 and 1 alpha, 25-dihydroxy-18,19-dinorvitamin D3. (1996) (17)
19nor-1,25-Dihydroxyvitamin D2 Specifically Induces CYP3A9 in Rat Intestine More Strongly than 1,25-Dihydroxyvitamin D3 in Vivo and in Vitro (2006) (16)
Vitamin D C-22 aldehydes. New key intermediates for the synthesis of side chain modified vitamin D analogues (1987) (16)
Vitamin D metabolism during pregnancy. (1986) (16)
The synthesis and activity in vitro of 25-masked-1α-hydroxylated vitamin D3 analogs (1978) (16)
The biochemical basis of renal osteodystrophy and post-menopausal osteoporosis: a view from the vitamin D system. (1981) (16)
Quantitation of endogenously occupied and unoccupied binding sites for 1,25-dihydroxyvitamin D3 in rat intestine. (1983) (16)
The biological activity of 5,6-epoxyretinoic acid. (1980) (16)
The transformation of a vitamin into a hormone: the vitamin D story. (1979) (16)
PARATHYROID HORMONE AND ANION UPTAKE IN ISOLATED MITOCHONDRIA. (1964) (16)
Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analog (2005) (16)
Stimulation of 25-hydroxyvitamin D/sub 3/-1. cap alpha. -hydroxylase by phosphate depletion (1976) (16)
UVB radiation, vitamin D and multiple sclerosis. (2017) (16)
Synthesis and determination of configuration of natural 25-hydroxyvitamin D(3) 26,23-lactone. (1981) (16)
Role of vitamin D in neonatal skeletal development in rats. (1986) (16)
Metabolism and biological activity of 25-fluorocholecalciferol, 24-dehydrocholecalciferol and 25-dehydrocholecalciferol in the rat. (1979) (16)
25-hydroxycholecalciferol for prevention of "milk fever" in dairy cows (1978) (16)
Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancer. (2015) (16)
Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation. (2014) (16)
Isolation of identification of 24(R)-hydroxyvitamin D3 from chicks give large doses of vitamin D3. (1981) (16)
New 1alpha,25-dihydroxy-19-norvitamin D(3) compounds constrained in a single A-ring conformation: synthesis of the analogues by ring-closing metathesis route and their biological evaluation. (2009) (16)
Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1alpha,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivity. (2007) (16)
ELECTROPHILIC ADDITION OF OSMIUM TETROXIDE TO 25-HYDROXYCHOLECALIFEROL AND ITS 3,5-CYCLO DERIVATIVE (1983) (16)
1 alpha-hydroxyvitamin D3 plus 25-hydroxyvitamin D3 reduces parturient paresis in dairy cows fed high dietary calcium. (1992) (16)
Metabolism of (1,2)3H-vitamin D3 and (26,27)3H-25-hydroxyvitamin D3 in rachitic chicks. (1970) (16)
Nuclear receptor 4A2 and C/EBPbeta regulate the parathyroid hormone-mediated transcriptional regulation of the 25-hydroxyvitamin D3-1alpha-hydroxylase. (2007) (15)
A new, highly sensitive assay for 1,25-dihydroxyvitamin D not requiring high-performance liquid chromatography: application of monoclonal antibody against vitamin D receptor to radioreceptor assay. (1992) (15)
Failure of conventional doses of 1 alpha, 25-dihydroxycholecalciferol to correct hypocalcemia in a girl with idiopathic hypoparathyroidism. (1977) (15)
The appearance of 1,25-dihydroxyvitamin D3 receptor during chick embryo development. (1985) (15)
The mechanism of adaptation of intestinal calcium absorption to low dietary calcium. (1971) (15)
1,25-Dihydroxyvitamin D3 target cells in immature pancreatic islets. (1987) (15)
Novel, Selective Vitamin D Analog Suppresses Parathyroid Hormone in Uremic Animals and Postmenopausal Women (2014) (15)
Recent advances in the metabolism and function of vitamin D. (1969) (15)
Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1a-hydroxylase gene in normocalcemic rats (vitamin D metabolismy1a-hydroxylaseyparathyroid hormone) (1999) (15)
Ruthenium tetroxide oxidation of Grundmann's ketone derived from vitamin D3 (1995) (15)
Hydroxylation of carbon-24 of 25-hydroxycholecalciferol is not necessary for normal embryonic development in chickens. (1984) (15)
Novel synthesis of 19-nor-vitamin d compounds (1991) (15)
Modern view of vitamin D3 and its medicinal uses. (1998) (15)
Synthesis of 1α-Fluorovitamin D3 (1984) (15)
Size and charge of the functional 1,25-dihydroxyvitamin D receptor in porcine intestine. (1987) (15)
Synthesis of 1α-hydroxyergocalciferol (1977) (15)
THE METABOLISM OF [6-3H]1α, HYDROXYCHOLECALCIFEROL TO [6-3H]1α, 25-DIHYDROXYCHOLECALCIFEROL IN A PATIENT WITH RENAL INSUFFICIENCY (1977) (15)
22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor. (2007) (15)
Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1α, 25-dihydroxyvitamin D3 (1999) (15)
A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines. (1997) (15)
Regulation of the intestinal 1,25-dihydroxyvitamin D3 receptor during neonatal development in the rat. (1988) (15)
Bacterial expression and characterization of the ligand-binding domain of the vitamin D receptor. (1999) (15)
Induction of calcium-binding protein in organ-cultured chick intestine by fluoro analogs of vitamin D3. (1981) (15)
Isolation of 5,8-oxyretinoic acid from rat intestinal mucosa. (1979) (14)
A study of the stereoselectivity of cyclopropanation of some .alpha.,.beta.-unsaturated aldehydes by ethyl (dimethylsulfuranylidene)acetate (1984) (14)
Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D₃ markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription. (2010) (14)
PARATHYROID HORMONE INTERACTION WITH THE OXIDATIVE PHOSPHORYLATION CHAIN. EFFECT ON ADENOSINE TRIPHOSPHATASE ACTIVITY AND THE ADENOSINE TRIPHOSPHATE-ORTHOPHOSPHATE EXCHANGE REACTION. (1964) (14)
Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro. (1984) (14)
Chemistry and biological activity of vitamin D, its metabolites and analogs. (1974) (14)
Metabolism and pharmacokinetics of 24,25-dihydroxyvitamin D3 in the vitamin D3-replete rat. (1985) (14)
Vitamin D binding protein is required to utilize skin-generated vitamin D (2019) (14)
Regulation of vitamin D metabolism. (1975) (14)
Aspects of teratology of vitamin A acid (beta-all-trans retinoic acid). (1975) (14)
A rapid assay for 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D 24-hydroxylase. (1990) (14)
Treatment of vitamin D-resistant rickets with 25-hydroxycholecalciferol. (1972) (14)
Chromatography of vitamin A compounds on silicic acid columns. (1968) (14)
Photoaffinity labeling of the 1,25-dihydroxyvitamin D-3 receptor. (1991) (14)
Interrelationships between thyrocalcitonin, parathyroid hormone and vitamin D: control of serum calcium in hypervitaminosis D. (1969) (14)
Calcium uptake by chorioallantoic membrane: effects of vitamins D and K. (1994) (14)
1,25-Dihydroxyvitamin D3 in childhood hepatic osteodystrophy. (1979) (14)
Kidney microsomal metabolism of 25-hydroxyvitamin D3+. (1977) (14)
Pseudovitamin D deficiency (vitamin D dependency) (1976) (13)
Survival of vitamin D-deficient embryos: time and choice of cholecalciferol or its metabolites for treatment in ovo. (1993) (13)
Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children. (1983) (13)
1-Desoxy analog of 2MD: Synthesis and biological activity of (20S)-25-hydroxy-2-methylene-19-norvitamin D3 (2010) (13)
The vitamin D system: a view from basic science to the clinic. (1981) (13)
The plasma binding protein for vitamin D is a site of discrimination against vitamin D-2 compounds by the chick. (1988) (13)
Action of parathyroid hormone on mitochondria. Magnesium- and phosphate-independent respiration. (1966) (13)
Oral 1,25(OH)2D3: An effective prophylactic treatment for glucocorticoid osteopenia in rats (2006) (13)
Biological activity of 1 α-hydroxyvitamin D2 in the rat (1978) (13)
Synthesis of potential vitamin d antagonists (1977) (13)
The biological activity of rat intestinal retinoic acid metabolites in the vaginal smear assay. (1983) (13)
1 alpha -Hydroxy derivative of vitamin D3: a highly potent analog of 1 alpha ,25-dihydroxyvitamin D3 (1973) (13)
Excessive cholecalciferol in a layers diet: decline in some aspects of reproductive performance and increased bone mineralisation of progeny. (1986) (13)
UV light suppression of EAE (a mouse model of multiple sclerosis) is independent of vitamin D and its receptor (2019) (13)
Vitamin A deficiency and urinary calcium excretion in rats. (1972) (13)
Photoaffinity labeling of serum vitamin D binding protein by 3-deoxy-3-azido-25-hydroxyvitamin D3. (1986) (13)
Synthesis of some side-chain homologues of 1 alpha,25-dihydroxyvitamin D3 and investigation of their biological activities. (1986) (13)
Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1α,25-dihydroxyvitamin D3 and 20-epi-2-methyl-1α,25-dihydroxyvitamin D3 (2001) (13)
Vitamin D deficiency independent of hypocalcemia elevates blood pressure in rats. (2015) (13)
A maternal defect is responsible for growth failure in vitamin D-deficient rat pups. (1984) (12)
EFFECT OF EGG WHITE DIETS ON CALCIUM METABOLISM IN THE RAT. (1963) (12)
A fluorinated vitamin D3 analog with biopotency greater than 1α,25-dihydroxy vitamin D3 (1980) (12)
Ring A-stereoisomers of 1-hydroxyvitamin D3 and their relative binding affinities for the intestinal 1α,25-dihydroxyvitamin D3 receptor protein (1985) (12)
Evidence for the metabolism of 24R-hydroxy-25-fluorovitamin D3 and 1α-hydroxy-25-fluorovitamin D3 to 1α,24R-dihydroxy-25-fluorovitamin D3☆ (1979) (12)
Activation of retinoic acid by coenzyme A for the formation of ethyl retinoate. (1985) (12)
Adaptation of intestinal calcium absorption: parathyroid hormone and vitamin D metabolism. (1978) (12)
Is there more to learn about functional vitamin D metabolism? (2015) (12)
Triennial Growth Symposium--Vitamin D: bones and beyond. (2014) (12)
The early time course of calcium-binding protein induction by 1,25-dihydroxyvitamin D3 as determined by computer analysis of two-dimensional electrophoresis gels. (1984) (12)
In vitro epoxidation of all-trans-retinoic acid in rat tissue homogenates. (1979) (12)
Recent progress in vitamin D metabolism and the chemistry of vitamin D metabolites. (1980) (12)
Synthesis of calcitroic acid, a metabolite of 1.alpha.,25-dihydroxycholecalciferol (1981) (12)
13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation. (2009) (12)
Vitamin D Binding Globulin in the Rat (1969) (11)
A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1α,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3. (2012) (11)
The action of vitamin D in vivo and in vitro on the release of calcium from kidney mitochondria. (1962) (11)
Contribution of several metabolites of the vitamin D analog 20-epi-22-oxa-24a,26a,27a-tri-homo-1,25-(OH)(2) vitamin D(3) (KH 1060) to the overall biological activity of KH1060 by a shared mechanism of action. (2000) (11)
The action of vitamin D in vivo and in vitro on the release of calcium from kidney mitochondria. (1962) (11)
Subcellular distribution of DNA-binding and non-DNA-binding 1,25-dihydroxyvitamin D receptors in chicken intestine. (1984) (11)
Analogs of 1α,25-Dihydroxyvitamin D₃ in Clinical Use. (2016) (11)
Multiple forms of vitamin D-dependent calcium-binding protein in rat kidney. (1984) (11)
Isotachysterol3 and 25-Hydroxyisotachysterol3: Analogs of 1,25-Dihydroxyvitamin D3 (1973) (11)
The stimulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase by estrogen. (1977) (11)
Vitamin D as a prohormone. (1977) (11)
2-Methylene-19-nor-1α-hydroxyvitamin D3 analogs inhibit adipocyte differentiation and PPARγ2 gene transcription (2007) (11)
Synthesis and biological activity of 25,26,27-trisnor-vitamin D3 24-oic acid and its 1α-hydroxyl analog (1979) (11)
Studies on organic fluorine compounds. L. Synthesis and biological activity of 2 alpha-fluorovitamin D3. (1986) (11)
Bone resorptive activity of side-chain fluoro derivatives of 25-hydroxy- and 1 alpha,25-dihydroxyvitamin D3 in culture. (1981) (11)
Biological activity of 24,24-difluoro-25-hydroxycholecalciferol in chicks. (1983) (11)
The vitamin D3 hydroxylase-associated protein is a propionamide-metabolizing amidase enzyme. (1995) (11)
Synthesis and determination of the configuration of 23,25-dihydroxy-vitamin D3; a new metabolite of vitamin D3; X-ray crystal structure of a 3,23,25-triol precursor (1981) (11)
A modified pGEX vector with a C-terminal histidine tag: recombinant double-tagged protein obtained in greater yield and purity. (1997) (11)
Analogs of the hormonal form of vitamin D and their possible use in leukemia. (1988) (10)
Chemical synthesis of (24R)-24,25-dihydroxy[26,27-3H]vitamin D3 of high specific activity. (1984) (10)
Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes. (2008) (10)
Action of 25-HydroxydihydrotachysteroL on Calcium Metabolism in Normal and Thyroparathyroidectomized Rats1 (1974) (10)
Inhibitors of the 25-hydroxylation of vitamin D3 in the rat (1980) (10)
Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1α-hydroxy-19-norvitamin D analogues with shortened alkyl side chains. (2011) (10)
Mechanism of action of 1,25-dihydroxyvitamin D3: 1990 version (1990) (10)
Plasma Levels of Vitamin D Metabolites in Fetal and Pregnant Ewes 1 (1987) (10)
The growth-supporting activity of a retinoidal benzoic acid derivative and 4,4-difluororetinoic acid. (1985) (10)
Structural analogs of lα,25-dihydroxycholecalciferol: Preparation and biologial assay of 1α-hydroxypregnacalciferol (1975) (10)
Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position. (2007) (10)
Circulating vitamin D metabolites in nephropathic cystinosis. (1983) (10)
On the side chain conformation of 1α,25-dihydroxyvitamin D3 responsible for binding to the receptor (1995) (10)
A radiometric immunosorbent assay for the detection of anti-hormone-binding protein antibodies. (1986) (10)
1 alpha,25-Dihydroxyvitamin D-induced modification of a cytosolic protein in embryonic chick intestine. (1985) (10)
Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1α,25-dihydroxyvitamin D3 (2004) (10)
Excretion of metabolites of 1?,25-dihydroxyvitamin D in rat bile (1980) (10)
Ethyl 13,14-dihydro-13,14-methyleneretinoates: analogs of all-trans- and 13-cis-retinoic acid (1984) (10)
Vitamin D: revisited 1980. (1980) (10)
Metabolites of all-trans-retinol in day 10 conceptuses of vitamin A-deficient rats. (1996) (10)
Differences in the side-chain metabolism of vitamin D3 between chickens and rats. (1985) (10)
Parathyroid hormone-induced mitochondrial swelling. (1966) (10)
Protein synthesis is required for optimal induction of 25-hydroxyvitamin D(3)-24-hydroxylase, osteocalcin, and osteopontin mRNA by 1,25-dihydroxyvitamin D(3). (2002) (10)
The effect of DPPD on the decarboxylation of retinoic acid in vitro and in vivo. (1969) (10)
1,25-dihydroxycholecalciferol analogs cannot replace vitamin D in normocalcemic male rats. (1993) (10)
Isolation and characterization of the chicken vitamin D receptor gene and its promoter (2000) (10)
New developments in the vitamin D endocrine system. (1982) (10)
Responsiveness of vitamin D-deficient fetal rat limb bones to parathyroid hormone in culture. (1983) (9)
Measurement of chick kidney 25-hydroxyvitamin D3-1 alpha-hydroxylase without use of radioactive substrate. (1981) (9)
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light (2016) (9)
Synthesis and biological evaluation of novel 6-substituted analogs of 1α,25-dihydroxy-19-norvitamin D3 (2013) (9)
Differential recruitment of coactivators to the vitamin D receptor transcriptional complex by 1alpha,25-dihydroxyvitamin D3 analogs. (2007) (9)
Highly potent 2-methylene analogs of 1α,25-dihydroxyvitamin D3: Synthesis and biological evaluation (2013) (9)
Stimulation of 24R,25-dihydroxyvitamin D3 synthesis by metabolites of vitamin D3. (1983) (9)
Effects of 1αOHD2 on bone tissue Studies of 1αOHD2 and 1αOHD3 in normal rats and in rats treated with prednisolone (1984) (9)
20-Oxopregnacalciferols: Vitamin D compounds that bind the progesterone receptor (1994) (9)
Intestine, Bone, and Mammary Gland Contributions to Maternal Plasma Calcium Increase after Abrupt Weaning (1992) (9)
Intestinal calcium-binding protein (CaBP) and bone calcium mobilization in response to 1,24(R),25-(OH)3D3. Comparative effects of 1,25-(OH)2D3 and 24(R),25-(OH)2D3 in rats. (1980) (9)
Synthesis and bioassay of 3-deoxy-1α-hydroxyvitamin D3, an active analog of 1α,25-dihydroxyvitamin D3 (1977) (9)
Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism (2016) (9)
The effects of vitamin D metabolites and their analogues on the secretion of parathyroid hormone (1975) (9)
The effects of vitamin D analogues on bone resorption (2005) (9)
The development of a bone- and parathyroid-specific analog of vitamin D: 2-methylene-19-Nor-(20S)-1α,25-dihydroxyvitamin D3. (2014) (9)
Cloning and expression of the chicken 25-hydroxyvitamin D3 24-hydroxylase cDNA. (1998) (9)
Baculovirus-mediated expression of retinoic acid receptor type gamma in cultured insect cells reveals a difference in specific DNA-binding behavior with the 1,25-dihydroxyvitamin D3 receptor. (1992) (9)
New derivative of 1α,25-dihydroxy-19-norvitamin D3 with 3′-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis (2004) (9)
Analysis of the binding sites of vitamin D 1α-hydroxylase (CYP27B1) and vitamin D 24-hydroxylase (CYP24A1) for the design of selective CYP24A1 inhibitors: Homology modelling, molecular dynamics simulations and identification of key binding requirements. (2017) (9)
A chick serum fraction that stimulates alkaline phosphatase activity in embryonic chick femora in culture. (1969) (9)
1,25-Dihydroxyvitamin D3 Is a Positive Regulator for the Two Anti-Encephalitogenic Cytokines TGF-β1 and IL-4 (1998) (9)
25-Hydroxycholecalciferol(25-OH-D3). 3. Effect of dosage on soft tissue integrity and vitamin D activity of tissue and milk from dairy cows. (1974) (9)
Chapter 30. Vitamin D Metabolites and Their Analogs (1980) (8)
Primary isotope effect of tritium on the hydroxylations of 25-hydroxyvitamin D3. (1982) (8)
Autoradiographic studies with 3H 1,25 (OH)2 vitamin D3 and 3H 25 (OH) vitamin D3 in rat parathyroid glands (1981) (8)
Novel Convergent Synthesis of Side-Chain-Modified Analogues of 1α,25-Dihydroxycholecalciferol and 1α,25-Dihydroxyergocalciferol. (1989) (8)
Remembrance: discovery of the vitamin D endocrine system. (1992) (8)
Synthesis and biological evaluation of 6-methyl analog of 1α,25-dihydroxyvitamin D3 (2010) (8)
Vitamin D-dependent calcium transport. (1985) (8)
PARATHYROID HORMONE-DEPENDENT TRANSPORT OF INORGANIC PHOSPHATE BY RAT LIVER MITOCHONDRIA. EFFECT OF PHOSPHORYLATION CHAIN INHIBITORS. (1965) (8)
Studies on organic fluorine compounds. LII. Synthesis and biological activity of 26,26,26,27,27-pentafluoro-1 alpha-hydroxy-27-methoxyvitamin D3. (1988) (8)
Synthesis, Conformational Analysis, and Biological-Activity of the 1-α,25-Dihydroxy-10,19-Dihydrovitamin D3 Isomers (1994) (8)
Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1α,25-(OH)2D3 (2007) (8)
Metabolism and biological activity of 24,25-dihydroxyvitamin D/sub 3/ in the chick (1976) (8)
Model of three-dimensional structure of VDR bound with Vitamin D3 analogs substituted at carbon-2 (2004) (8)
Metabolism and Biological Activity of 24 , 25 Dihydroxyvitamin D , in the Chick * (8)
New highly calcemic 1α,25-dihydroxy-19-norvitamin D3 compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series (2002) (8)
The biological activity of cyclopropyl analogs of all-trans- and 13-cis-retinoic acid in the rat vaginal smear assay. (1985) (8)
Responses of fetal rat bones to Solanum malacoxylon in vitro: a possible explanation of previous paradoxical results. (1978) (8)
Synthesis of 1β-hydroxyvitamin D3 and 1β,25-dihydroxyvitamin D3 (1978) (8)
1,25-DIHYDROXYCHOLECALCIFEROL IN HYPOPARATHYROIDISM AND PSEUDOHYPOPARATHYROIDISM (1975) (8)
New 1α,25-dihydroxy-19-norvitamin D3 analogs with a frozen A-ring conformation (2010) (8)
Significance of proteolytic activity in 1,25-(OH)2D3-induced differentiation of HL-60 cells. (1991) (7)
CHAPTER 1 – Historical Perspective (2005) (7)
Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy. (1980) (7)
Δ22-Unsaturated analogs of vitamin D3 and their C(1)-hydroxylated derivatives (1987) (7)
Synthesis and Biological Activity of 25-Hydroxy-2-methylene-vitamin D3 analogues monohydroxylated in the A-ring. (2014) (7)
The action of 1 alpha,25-dihydroxyvitamin D3 on rat small intestine: changes in translatable mRNA species. (1985) (7)
Response to Vitamin D in Adrenalectomized Animals (1966) (7)
Molybdate and the 1,25-dihydroxyvitamin D3 receptor from chick intestine. (1985) (7)
Regulation of vitamin D metabolism in the kidney. (1977) (7)
Complex carbohydrate diets are not capable of maintaining normal plasma calcium and phosphorus levels in vitamin D-deficient rats. (1984) (7)
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial (2016) (7)
Determination of vitamin D metabolites. (1978) (7)
Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia. (1972) (7)
13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation. (2011) (7)
Effect of 1,25-dihydroxyvitamin D3 on mouse thymus: role of extracellular calcium. (1996) (7)
A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1α,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo. (2015) (7)
A characterization of vitamin D-independent intestinal calcium absorption in the osteopetrotic (op/op) mouse. (1999) (7)
Photoactivable analogs for labeling 25-hydroxyvitamin D3 serum binding protein and for 1,25-dihydroxyvitamin D3 intestinal receptor protein. (1986) (7)
Purification and properties of an 18-kilodalton, 1,25-dihydroxyvitamin D3 modulated protein from embryonic chick intestine. (1988) (7)
The biological activity and metabolism of 24,25-dihydroxyvitamin D 3 . (1973) (7)
The Vitamin D-Caicium Axis-1983 (1985) (7)
Synthesis of (22R)- and (22S)-22,25-Dihydroxyvitamin D3 and determination of their biological activity. (1981) (7)
Solubilization and partial purification of a rat intestinal 1,25-dihydroxyvitamin d3 binding protein (1975) (7)
Studies on the role of 24-hydroxylation of vitamin D in the mineralization of cartilage and bone of vitamin D-deficient rats (2006) (7)
On the specificity of vitamin D compounds binding to chick pig intestinal 1,25-dihydroxyvitamin D3 receptor (1988) (7)
Vitamin D deficiency in the ApcPirc/+ rat does not exacerbate colonic tumorigenesis, while low dietary calcium might be protective (2018) (6)
2-Methylene analogs of 1α-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor (2004) (6)
The influence of substitution at C24 on the calcium-binding protein-stimulating activity of vitamin D metabolites in chick embryonic duodenum. (1979) (6)
Monoclonal antibodies to human vitamin D-binding protein. (1985) (6)
In vivo and in vitro inhibition of rat liver vitamin D3-25-hydroxylase activity by 19-hydroxy-10(S),19-dihydrovitamin D3. (1980) (6)
Differentiation of neoplastic cells toward normal induced by vitamin D3 derivatives. (1994) (6)
High-performance liquid chromatography of vitamin D and its application to endocrinology. (1988) (6)
SYNTHETIC STUDIES OF VITAMIN D3 ANALOGS FROM BILE ACIDS. PART 3. SYNTHESES OF F 1α,25‐, 1α,24R‐, AND 1α,24S‐DIHYDROXYCHOLECALCIFEROLS FROM LITHOCHOLIC ACID AND THEIR BIOLOGICAL ACTIVITIES (1979) (6)
Parathyroid hormone is not involved in 1,25-dihydroxyvitamin D regulation of 25-hydroxyvitamin D metabolism in vivo. (1981) (6)
Novel 9-Alkyl- and 9-Alkylidene-Substituted 1α,25-Dihydroxyvitamin D3 Analogues: Synthesis and Biological Examinations. (2015) (6)
26,27-Dihomo-1 alpha-hydroxy- and 26,27-dihomo-24-epi-1 alpha,25-dihydroxyvitamin D2 analogs that differ markedly in biological activity in vivo. (1994) (6)
Excretion of metabolites of 1 alpha, 25-dihydroxyvitamin D3 in rat bile. (1980) (6)
Synthesis of 6,7-diaza-19-norvitamin D compounds (1995) (6)
16 – Significance of Vitamin D in Age-Related Bone Disease (1986) (6)
Ethanol-Induced Artifacts in the Metabolism of 3H‐Vitamin D3 (1969) (6)
Lack of biological activity of physiological metabolites of all-trans-retinoic acid on vaginal epithelial differentiation. (1987) (6)
Variations in lipid intake and their influence on respiration and tricarboxylic acid cycle activity. (1965) (6)
Novel styryl-indoles as small molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): Synthesis and biological evaluation. (2014) (6)
Biological activity of 24,24-difluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in inducing differentiation of human myeloid leukemia cells. (1983) (6)
Salate derivatives found in sunscreens block experimental autoimmune encephalomyelitis in mice (2017) (6)
Long‐term therapy of vitamin D‐resistant rickets with 25‐hydroxycholecalciferol (1975) (6)
cDNA cloning and characterization of a vitamin D3 hydroxylase-associated protein. (1994) (6)
Analysis of basal regulatory elements in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene promoter. (2001) (6)
Assay and properties of rat yolk sac 25-hydroxyvitamin D3 1 alpha-hydroxylase. (1986) (6)
Synthesis and biological activity of (22E,24R)- and (22E,24S)-1 alpha,24-dihydroxy-22-dehydrovitamin D3. (1984) (6)
Vitamin D: 1973 (1973) (6)
Role of 1 , 25-Dihydroxyvitamin D 3 in Maintaining Serum Phosphorus and Curing Rickets ( bone / calcification / transport / vitamin D ) (6)
In vitro inhibitor studies of vitamin D 25-hydroxylase in rat liver microsomes. (1983) (6)
838 SERUM 1,25-(0H)2-VITAMIN O3 LEVELS IN CHILDREN AND ALTERATION WITH DISORDERS OF VITAMIN D METABOLISM (1978) (6)
Conformationally Restricted Analogues of 1α,25‐Dihydroxyvitamin D3 and Its 20‐Epimer: Compounds for Study of the Three‐Dimensional Structure of Vitamin D Responsible for Binding to the Receptor. (1996) (6)
Effective Treatment of Hypophosphatemic Vitamin D Resistant Rickets (VDRR) with 25-Hydroxychole-calciferol (25-HCC) (1970) (6)
Moderate hypocalcemia due to normal serum 1,25-dihydroxyvitamin D levels in an asymptomatic kindred with familial hypoparathyroidism. (1987) (6)
New developments in the vitamin D endocrine system. (1982) (6)
Preparation of tritium- or deuterium-labeled vitamin D analogs by a convenient general method. (1981) (6)
Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid (2017) (6)
Separation of Two Forms of Chick 1,25-Dihydroxyvitamin D3 and 25-Hydroxyvitamin D3 24-Hydroxylase (1994) (6)
A Concise Synthesis of an AHR Endogenous Ligand with the Indolecarbonylthiazole Skeleton (2003) (6)
The Association of Mineral Metabolism with Vascular Access Patency (2016) (5)
Effect of treatment with synthetic 1,25-dihydroxyvitamin D in postmenopausal osteoporosis (1978) (5)
1α-Hydroxy D 3 with and without oestrogen in the treatment of osteoporosis (1981) (5)
Synthesis and biological activity of 25-hydroxy-2-methylene-vitamin D3 compounds (2013) (5)
Regulation of cellular retinol binding protein type II by 1,25-dihydroxyvitamin D3. (1990) (5)
Synthesis of 25-hydroxy-[26,27-3H]vitamin D2, 1,25-dihydroxy-[26,27-3H]vitamin D2 and their (24R)-epimers. (1987) (5)
Two new vitamin D isomers. Formation of (3S,10R)-(Z,Z)-9,10-secocholesta-5,7,14-trien-3-ol and its 10S-epimer from cis-isotachysterol3 via facile [1,7]sigmatropic rearrangements (1978) (5)
THE INTERACTION OF VITAMIN D PARATHYROID HORMONE AND THYROCALCITONIN. (1967) (5)
Vitamin A and bone metabolism in the rat. (1973) (5)
Metabolism of vitamins D and A. (1969) (5)
Subcellular mechanisms involving vitamin D. (1981) (5)
Synthetic Analogs of 1α,25-Dihydroxyvitamin D3 and Their Biological Activity (1975) (5)
A microassay for mammalian renal 25-hydroxyvitamin D3-1-hydroxylase applicable to man. (1983) (5)
2-Methylene-19-nor-1alpha-hydroxyvitamin D3 analogs inhibit adipocyte differentiation and PPARgamma2 gene transcription. (2007) (5)
Synthesis of novel 19-norvitamin D3 analogs with unnatural triene system (2013) (5)
Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis. (1984) (5)
24-hydroxylation of 1,25-dihydroxyvitamin D/sub 3/. [Rats, chickens] (1977) (5)
Long term follow-up of bone mineral status in children with renal disease (2004) (5)
The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1 (cid:2) ,25-dihydroxyvitamin D 3 (2014) (5)
Biological Activity of 1,24(R)-Dihydroxyvitamin 3 and 1,24(S)-Dihydroxyvitamin D3 in the Rat 1 (1982) (5)
1,25-Dihydroxyvitamin D and not Calcium Is the Major Regulator of Calbindin-D 9-kDa mRNA Levels In Vivo (1992) (5)
Structure and regulation of the rat 1 , 25-dihydroxyvitamin D 3 receptor ( vitamin D / steroid receptor / calcium transport / steroid receptor cDNA ) (5)
Vitamin D-3-sensitive Ca-45 binding by microsomal preparations from chick intestinal mucosa. (1965) (5)
The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis. (2009) (5)
26-Hydroxylation of 1α,25-Dihydroxyvitamin D3 Does Not Occur under Physiological Conditions (2001) (5)
Computer analysis of double-labeled two-dimensional electrophoresis gels. (1985) (5)
Recent progress in vitamin D metabolism and the chemistry of vitamin D metabolites. (1980) (5)
Osteopetrotic (op/op) mice are unable to maintain serum calcium levels despite hyperabsorption of calcium. (1996) (5)
THE PREPARATION OF H3-VITAMINS D2 AND D3--THEIR LOCALIZATION IN THE RAT. (1963) (5)
Mitochondrial cytochrome p450. A component of chick kidney 25-hydrocholecalciferol-1alpha-hydroxylase. (1974) (5)
Erratum: An investigation of sources of variation in calcium absorption efficiency (Journal of Clinical Endocrinology and Metabolism (1995) 80 (406- 411)) (1995) (5)
Additional protein factors play a role in the formation of VDR/RXR complexes on vitamin D response elements (1998) (5)
2-Methylene-19-nor-20(S)-1α-hydroxy-bishomopregnacalciferol [20(S)-2MbisP], an analog of vitamin D3 [1,25(OH)2D3], does not stimulate intestinal phosphate absorption at levels previously shown to suppress parathyroid hormone (2008) (5)
2-(3′-Hydroxypropylidene)-1α-hydroxy-19-norvitamin D compounds with truncated side chains (2007) (4)
An analog of 1α,25-dihydroxy-19-norvitamin D3 with the 1α-hydroxy group fixed in the axial position lacks biological activity in vitro (2007) (4)
A convenient synthesis of (24S)-1α-hydroxyvitamin D2 (1989) (4)
Calcium intake and bone. (1985) (4)
Response of protracted neonatal hypocalcaemia to 1alpha,25-dihydroxyvitamin D3. (1976) (4)
The importance of early treatment of renal bone disease in children. (1985) (4)
The effect of dietary protein on the biological activity of cholecalciferol and its metabolites in the rachitic rat. (1980) (4)
24,25-Dihydroxyvitamin D3 administration increases incidence of parturient paresis. (1984) (4)
The epithelial differentiating activity in vivo of (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl) -1-propenyl]benzoic acid and 4,4-difluororetinoic acid. (1985) (4)
Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds. (2015) (4)
High-pressure liquid chromatography of vitamin A metabolites and analogs. (1980) (4)
Metabolites of dihydrotachysterol in target tissues. (1972) (4)
Activation and fusion induced by la , 25-dihydroxyvitamin D 3 and their relation in alveolar macrophages ( cell fusion / glucose consumption / Fc receptor / cytotoxicity ) (4)
Synthesis of (6-/sup 3/H)-1. cap alpha. -hydroxyvitamin D/sub 3/ and its metabolism in vivo to (/sup 3/H)-1,25-dihydroxyvitamin D/sub 3/. [Rats] (1975) (4)
Current concepts. Vitamin D. (1969) (4)
Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides. (2017) (4)
Immunoaffinity purification of active rat recombinant 1,25-dihydroxyvitamin D3 receptor. (1994) (4)
Synthesis of coenzyme A ester of retinoic acid: intermediate in vitamin A metabolism. (1986) (4)
VITAMIN D METABOLISM (1977) (4)
Discovery of the vitamin D endocrine system. (1997) (4)
Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D3 analogues (2017) (4)
26- and 27-Methyl groups of 2-substituted, 19-nor-1α,25-dihydroxylated vitamin D compounds are essential for calcium mobilization in vivo. (2013) (4)
Short-term regulation of the renal vitamin D receptor in rats by 1,25-dihydroxycholecalciferol is calcium insensitive. (1992) (4)
Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3). (2001) (4)
Vitamin D today. (1975) (4)
Analogs of the hormonal form of vitamin D and their possible use in leukemia. (1988) (4)
1,25-Dihydroxyvitamin D3 normalizes maternal food consumption and pup growth in rats. (1984) (4)
METABOLISM AND MECHANISM OF ACTION OF 25- HYDROXYCHOLECALCIFEROL* (1971) (4)
Modulation of protein biosynthesis during early stages of differentiation in retinoic acid treated F9 teratocarcinoma cells. (1986) (4)
Biosynthesis of retinoyl-beta-glucuronide, a biologically active metabolite of all-trans-retinoic acid. (1986) (3)
Antirachitic activity of 1 alpha-hydroxyergocalciferol and 1 alpha-hydroxycholecalciferol in rats. (1984) (3)
An alteration in the plasma levels of 1,25 dihydroxycholecalciferol is not responsible for the bone lesion in chronic cadmium exposure in dogs (1980) (3)
Influence of a Diphosphonate and 1,25-Dihydroxycholecalciferol on Calcium Metabolism (1975) (3)
Growth velocity in a child on prolonged hemodialysis. Beneficial effect of 1-alpha-hydroxyvitamin D3. (1977) (3)
Chapter 1 – Historical Overview of Vitamin D (2018) (3)
SYNTHESIS OF CALCITROIC ACID, A METABOLITE OF 1α,25‐DIHYDROXYCHOLECALCIFEROL (1981) (3)
The metabolism and function of 1α-hydroxyvitamin D3 (1975) (3)
Vitamin D esters are the major form of vitamin D produced by UV irradiation in mice (2022) (3)
Vitamin D and Urinary Amino Acid Excretion in the Rat.∗ (1961) (3)
SYNTHESIS AND DETERMINATION OF THE CONFIGURATION OF 23,25-DIHYDROXYVITAMIN D3, A NEW METABOLITE OF VITAMIN D3. X-RAY CRYSTAL STRUCTURE OF A 3,23,25-TRIOL PRECURSOR (1982) (3)
A new tritium-release assay for 25-hydroxyvitamin D-1α-hydroxylase (1987) (3)
Synthesis and Biological Activity of 2,22-Dimethylene Analogues of 19-Norcalcitriol and Related Compounds. (2020) (3)
USE OF 1 ALPHA-HYDROXYVITAMIN D3 ON CHILDREN WITH CHRONIC RENAL FAILURE (1974) (3)
Vitamin D Metabolism and its Relationship to Pathologies of Calcium Metabolism (1976) (3)
Calcium homeostasis (1963) (3)
Synthesis and Biological Evaluation of Cyclopropylamine Vitamin D‐Like CYP24A1 Inhibitors (2017) (3)
Vitamin D receptor absence does not enhance intestinal tumorigenesis in ApcPirc/+rats (2022) (3)
Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis (2017) (3)
Vitamin D-resistant rickets: End-organ unresponsiveness (1980) (3)
Vitamin D: new horizons. (1971) (3)
Biological activity of 1 alpha-hydroxyvitamin D2 in the rat. (1978) (3)
Characterization of a receptor-like protein for 1 , 25-dihydroxyvitamin D 3 in rat skin ( vitamin D / epidermis / receptor ) (3)
Identification of a new all-trans-retinol metabolite produced through a new retinol metabolic pathway. (1998) (3)
Lack of response of bone mineralization of chicks fed egg yolks from hens on dietary 1,25 dihydroxycholecalciferol. (1987) (3)
Chapter 29 – The Genetics and Biology of Vitamin D (1997) (3)
Bone organ culture bioassay for the determination of 1,25-(OH)2D3 (1977) (3)
1alpha-Hydroxyvitamin D2: a potent synthetic analog of vitamin D2. (1975) (3)
Subject Index, Vol. 15, 1981 (1981) (3)
Ring-A-seco analogs of 1α,25-dihydroxy-19-norvitamin D3 (2013) (3)
Metabolic bone disease in long-term total parenteral nutrition. (1985) (3)
Evolution of our understanding of vitamin (2008) (3)
Effect of ethane-1-hydroxy-1,1-diphosphonate and vitamin D on bone mineralization (1979) (3)
Abstracts of the first International Conference on Steroids and Bone (2004) (2)
Chapter 74 – Alterations in 1,25-Dihydroxyvitamin D3 Structure that Produce Profound Changes in in Vivo Activity (2011) (2)
Retinoic Acid 5 , 6-Epoxidase (2)
Preparation of radiolabeled 9-cis- and all-trans-retinoids. (1997) (2)
The effect of 1α-hydroxyvitamin D2 on calcium metabolism in glucocorticoid-treated rats (1985) (2)
Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation. (2007) (2)
[18] Assay of 25-hydroxyvitamin D 1α-hydroxylase and 24-hydroxylase (1997) (2)
Identification of a vitamin D-response element in the rat calcidiol ( 25-hydroxyvitamin D 3 ) 24-hydroxylase gene ( caUm / bone / hydroxylwse / sterold receptor ) (2004) (2)
Introduction for the Symposia Entitled: Newly Discovered Actions of 1,25-Dihydroxyvitamin D3 and Osteoporosis: Basis and Treatment (1989) (2)
A New 1,25 Dihydroxy Vitamin D Analog with Strong Bone Anabolic Activity in OVX Rats with Little or no Bone Resorptive Activity (2020) (2)
Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid (2017) (2)
Vitamin D-resistant rickets. A prototype of nutritional management of a genetic disorder. (1979) (2)
Actinomycin D Inhibition of Vitamin D Action (1965) (2)
Quantitation of endogenously occupied and unoccupied receptors for 1,25-(OH)2D3 in rat duodenum (1982) (2)
Isotachysterol-3 and 25-hydroxyisotachysterol-3: analogs of 1,25-dihydrox vitamin D3. (1973) (2)
[Vitamin D metabolites as hormones in the regulation of calcium and phosphate metabolism]. (1973) (2)
Reply to Handunnetthi and Ramagopalan: UV radiation, experimental autoimmune encephalomyelitis, and multiple sclerosis (2010) (2)
[50] Purification and properties of vitamin D hydroxylases (1980) (2)
Method for sequencing foreign genes expressed from the polyhedrin promoter of recombinant baculoviruses. (1995) (2)
CHAPTER 11 – 25-Hydroxycholecalciferol: A Hormonal Form of Vitamin D1 (1972) (2)
In vivo side chain oxidation of 1,25 dihydroxyvitamin D3 (1976) (2)
[246] Vitamin D (1971) (2)
20-Oxopregnacalciferols: Vitamin D Compounds That Bind the Progesterone Receptor. (1994) (2)
Synthesis of novel 20-oxo-pregnacalciferol analogs with binding affinity to the progesterone receptor (1995) (2)
Effects of 1 alpha OHD2 on bone tissue. Studies of 1 alpha OHD2 and 1 alpha OHD3 in normal rats and in rats treated with prednisolone. (1984) (2)
Action of 1,25-dihydroxyvitamin D/sub 3/ and a diphosphonate on calcium metabolism in rats. [/sup 45/Ca] (1975) (2)
Synthesis of 9‐cis‐retinoic acid and C‐20‐[3H3C]‐9‐cis‐retinoic acid with high specific activity (1997) (2)
Synthetic studies of vitamin D3 analogues from bile acids. Part 3. Syntheses of 1 alpha,25-, 1 alpha,24R-, and 1 alpha,24S-dihydroxycholecalciferols from lithocholic acid and their biological activities. (1979) (2)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF 1α-FLUORO-25-HYDROXYVITAMIN D3 (1985) (2)
Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1alpha,25-(OH)2D3. (2007) (2)
Solubilization and partial purification of a rat intestinal 1,25-dihydroxyvitamin d3 binding protein (1976) (2)
Overproduction of rat 1 , 25-dihydroxyvitamin D 3 receptor in insect cells using the baculovirus expression system ( vitamin D / steroid receptor cDNA / expression system ) (2)
D-seco-Vitamin D analogs having reversed configurations at C-13 and C-14: Synthesis, docking studies and biological evaluation (2017) (2)
Efficient stable isotope labeling and purification of vitamin D receptor from inclusion bodies. (2012) (2)
Subcellular Location and Properties of Rat Renal 25-Hydroxyvitamin D3-l~-hydroxylase* (2001) (2)
Metabolism and serum protein binding of 3H-vitamin D4 in vitamin D-resistant rickets. (1969) (2)
A nuclear protein essential for binding of rat 1 , 25-dihydroxyvitamin D 3 receptor to its response elements ( vitamin D / steroid receptor / accessory protein ) (2004) (2)
YY1 regulates VDR/RXR- and TGFIIB-mediated transactivation of the vitamin D responsive osteocalcin gene (1996) (2)
Handbook of lipid research. Volume 2. The fat-soluble vitamins. (1978) (2)
The metabolism of [6-3H]1alpha, hydroxycholecalciferol to [6-3H]1alpha,25-dihydroxycholecalciferol in a patient with renal insufficiency. (1977) (2)
Metabolism and biological activity of vitamin D (2005) (2)
Ruthenium Tetroxide Oxidation of Grundmann′s Ketone Derived from Vitamin D3. (1995) (2)
Vitamin D, Gene Expression, and Cancer (1995) (1)
Methylation of the vitamin D-dependent CaBP gene (calbindin 9 Kd) does not mediate tissue or vitamin D regulation. (1989) (1)
Biological activity of 1alpha-hydroxyvitamin D3 in the rat. (1975) (1)
The Vitamin D System: Receptor, Analogs and Functions (2004) (1)
CHAPTER 87 – 2-Carbon-Modified Analogs of 19-Nor-1α,25-Dihydroxyvitamin D3 (2005) (1)
Vitamin D Effects on Intraocular Pressure in Nonhuman Primates (2010) (1)
Novel Superagonist Analogs of 2-Methylene Calcitriol: Design, Molecular Docking, Synthesis and Biological Evaluation (2021) (1)
Synthesis of 1. cap alpha. -Hydroxy (6-/sup 3/H) vitamin D/sub 3/ and its metabolism to 1. cap alpha. , 25-dihydroxy (6-/sup 3/H) vitamin D/sub 3/ in the rat (1976) (1)
Vitamin D and its Metabolites: Physiology, Biochemistry and Pharmacology (1979) (1)
ASBMR 25th Annual Meeting M001–M483 (2003) (1)
Nonskeletal effects of vitamin D (2020) (1)
Metabolism and Pharmacokinetics of 24 , 25-Dihydroxyvitamin D 3 in the Vitamin D 3-replete Rat * (1)
Partial amino acid sequence of porcine 1 , 25-dihydroxyvitamin D 3 receptor isolated by immunoaffinity chromatography ( calcium metabolism / vitamin D function / intestinal absorption / vitamin D metabolism / steroid receptors ) (1)
Absence of seasonal fluctuation in serum concentration of 24,25(OH)2-vitamin D in childhood (1982) (1)
Method of preventing milk fever in dairy cattle (1984) (1)
On transcalciferin, the serum binding protein for 25-hydroxycholecalciferol (1977) (1)
A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines. (1997) (1)
Action of 25-hydroxydihydrotachysterol3 on calcium metabolism in normal and thyroparathyroidectomized rats. (1974) (1)
A STUDY OF THE STEREOSELECTIVITY OF CYCLOPROPANATION OF SOME α,β-UNSATURATED ALDEHYDES BY ETHYL (DIMETHYLSULFURANYLIDENE)ACETATE (1984) (1)
Investigation on the potential role of the Ah receptor nuclear translocator protein in vitamin D receptor action. (1993) (1)
SOLID-STATE CONFORMATIONS OF VITAMIN D3 (1977) (1)
Vitamin D binding protein greatly improves bioactivity but is not essential for orally administered vitamin D (2021) (1)
Research priorities in the field of vitamin deficiency in man. (1979) (1)
Vitamin D metabolism: recent developments. (1973) (1)
Long-term therapy of viramin D-resistant richets with 25-hydroxycholecalciferol. (1975) (1)
Synthesis and biological activity of 25,26,27-trisnor-vitamin D3 24-oic acid and its 1 alpha-hydroxyl analog. (1979) (1)
Synthesis and biological activity of 3-deoxy-1alpha-hydroxyvitamin D3. (1974) (1)
Effect of 1,25-dihydroxycholecalciferol (1,25-D3) on linear growth and bone remineralization in childhood uremic osteodystrophy (1978) (1)
Effects of 25-hydroxycholecalciferol on urinary electrolyte excretion in hypophosphataemic rickets. (1974) (1)
1α-hydroxyvitamin D : A comparative study in children (1976) (1)
1,25-dihydroxycholecalciferol: a hormonal form of vitamin D active on intestine. (1972) (1)
Vitamin D Metabolism in Normal and Chronic Kidney Disease States (2016) (1)
Mechanism of action of 1,25-dihydroxyvitamin D on target gene expression. (1992) (1)
Assay of 25-hydroxyvitamin D 1 alpha-hydroxylase and 24-hydroxylase. (1997) (1)
Calcium metabolism. (1975) (1)
2P032 Crystal structures of vitamin D receptor in complex with lithocholic acid derivatives(29. Protein structure and dynamics (II),Poster Session,Abstract,Meeting Program of EABS & BSJ 2006) (2006) (1)
Vitamin D is not required for adaptive immunity to listeria (2019) (1)
392 THE CIRCULATING LEVELS OF VITAMIN D METABOLITES IN VITAMIN D DEFICIENCY: THE MEANING OF NORMAL CALCITRIOL (l,250H2-VITAMIN D) LEVELS (1981) (1)
1983 Bristol‐Myers Award for Distinguished Achievement in Nutrition Research (1984) (1)
Regulation of the vitamin D endocrine system located in the kidney. (1978) (1)
Method for sequencing foreign genes expressed from the polyhedrin promoter of recombinant baculoviruses. (1995) (1)
Sarcoidosis and its relationship to vitamin D (1977) (1)
Antibody production in mice requires neither vitamin D, nor the vitamin D receptor (2022) (1)
Vitamin D Analogs and the Treatment of Cancer (1990) (1)
338 A NEW TYPE OF RICKETS: UNRESPONSIVENESS OF BONE AND INTESTINE TO HIGH LEVELS OF ENDOGENOUSLY SYNTHESIZED 1,25-DIHYDROXYVITAMIN D3 [1,25(0H)2D3] (1978) (1)
A new suprasterol by photochemical reaction of 1α,25-dihydroxy-9-methylene-19-norvitamin D3. (2016) (1)
Stereoselective Syntheses of (22R)‐ and (22S)‐22‐Methyl‐1α,25‐ dihydroxyvitamin D3: Active Vitamin D3 Analogs with Restricted Side Chain Conformation. (1993) (1)
24-and 26-homo-1 , 25-dihydroxyvitamin D 3 : Preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro ( myeloid leukemia / 1 , 25-dihydroxyvitamin D 3 / celi differentiation ) (2003) (1)
Process for the preparation of 1alpha, 25-dihydroxycholecalciferol, a compound with improved antirachitic properties compared to vitamin D2, and D3, and which has value as a ADDING substance for impregnation agents, and relates to intermediates for their preparation (1976) (0)
Special issue on vitamin D (2007) (0)
An analog of 1alpha,25-dihydroxy-19-norvitamin D3 with the 1alpha-hydroxy group fixed in the axial position lacks biological activity in vitro. (2007) (0)
Evidence for the metabolism of 24R-hydroxy-25-fluorovitamin D3 and 1alpha-hydroxy-25-fluorovitamin D3 to 1alpha,24R-dihydroxy-25-fluorovitamin D3. (1979) (0)
Synthesis of indolthiazolverbindungen as ligands of the Ah receptor (2003) (0)
A Convenient Synthesis of (2aS)-1α-Hydroxyvitamin D2. (1990) (0)
New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis. (2004) (0)
Osteoporosis : recent advances in pathogenesis and treatment : proceedings of the 10th Steenbock Symposium, held at the University of Wisconsin--Madison, June 9-12, 1980 (1981) (0)
Pharmacoklnetics:An Introduction. (1980) (0)
Synthesis of 6,7-Diaza-19-norvitamin D Compounds. (1995) (0)
17.20 (s) -dehydro-vitamin D analogues and their uses (2005) (0)
Use of Vitamin D Compounds in Medicine, Especially 1,25-Dihydroxyvitamin D3 (1979) (0)
Mechanisms of calcium transport in small intestine. Overall review of the contract, September 1, 1972--March 1, 1976 (1976) (0)
Mechanisms of calcium transport in small intestine. Overall review of the contract, September 1, 1972--March 1, 1975 (1975) (0)
New synthesis of compounds of 19-nor-vitamin d. (1992) (0)
Vitamin D on absorption and retention of lead. (1980) (0)
26-Desmethyl-2-methylene-22-ene-19-nor-1α,25-dihydroxyvitamin D3 compounds selectively active on intestine (2014) (0)
Process for the preparation of compounds of the vitamin D substituted in position 1 by a hydroxy group from compounds of the 5,6-trans-vitamin D compounds thus obtained and (1980) (0)
analogues of 1a-hydroxyvitamin D2, their process for the preparation and pharmaceutical compositions containing them (1985) (0)
Process for the preparation of vitamin D compounds (1991) (0)
Peripheral Metabolism of Retinoids1 (1985) (0)
Derive 1a, 25-dihydroxy vitamin D2 and intermediate products for their preparation and pharmaceutical compositions comprising such derivatives (1984) (0)
The D Vitamins and Their Precursors (1979) (0)
26,27-dimethylene-1-alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and processes for their preparation (1992) (0)
[Current progress in the study of vitamin D--discovery of active vitamin D]. (1969) (0)
Phosphate inhibition of citrate oxidation in kidney tissue. (1959) (0)
Vitamin D derivatives deep 3, process for their preparation and containing the same drug (1978) (0)
Regulation of vitamin D metabolism: a new dimension in calcium homeostasis. (1972) (0)
Small molecule inhibitors of 25 hydroxyvitamin D 24 hydroxylase ( CYP 24 A 1 ) : synthesis and biological evaluation (2019) (0)
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxyvitamin D3 and a synthetic peptide containing the NR2 box of DRIP 205 (2004) (0)
2-methylene-19-nor-1 (Alfha) -hydroxy-17-ene-hemopregnacalciferol and their uses. (2005) (0)
1,25-Dihydroxyvitamin D Receptor Purification and Structural Determination (1990) (0)
Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and the NR2 Box of DRIP 205 (2007) (0)
The impact of recent findings concerning vitamin d metabolism on clinical medicine. (1974) (0)
The 1,25-Dihydroxycholecalciferol Receptor (1987) (0)
Synthetic analogs of 1alpha,25-dihydroxyvitamin D3 and their biological activity. (1974) (0)
Composes de 2-propylidene-19-nor-vitamine d (2004) (0)
STEROID STUDIES. 77. SYNTHESIS OF (22R- AND (22S)-22,25-DIHYDROXYVITAMIN D3 AND DETERMINATION OF THEIR BIOLOGICAL ACTIVITY (1982) (0)
Protective effect of 1 25 di hydroxy vitamin d against bone loss in oophorectomized rats (1982) (0)
Anthony W Norman, PhD, Biochemist, Mentor, Distinguished Professor, and Principal Steward of Vitamin D Science (1938–2019) (2019) (0)
Process for the preparation of 1-alpha-hydroxyvitamin D compounds (1986) (0)
A fluorinated vitamin D3 analog with biopotency greater than 1 alpha, 25-dihydroxy vitamin D3. (1980) (0)
MECHANISMS OF CALCIUM TRANSPORT IN SMALL INTESTINE. Overall Review of the Contract, January 1, 1970--September 1, 1972. (1972) (0)
817 – VITAMIN D AND ITS METABOLITES: PHYSIOLOGY, BIOCHEMISTRY, AND PHARMACOLOGY (1978) (0)
Assay and properties of rat yolk sac 25-hydroxyvitamin D/sub 3/ 1. cap alpha. -hydroxylase (1986) (0)
2-methylene-19,26,27-trinor (20s) -1-alpha-hydroxyvitamin D3 and uses thereof (2005) (0)
A process for the production of vitamin D2 compounds, and their 1-alpha hydrogenated derivatives. (1991) (0)
Osteoporosis : physiological basis, assessment, and treatment : proceedings of the Ninteenth Steenbock Symposium, held June 5 through June 8, 1989 at the University of Wisconsin-Madison, U.S.A. (1990) (0)
Method for assaying 1,25-dihydroxy vitamin d (1993) (0)
Process for the preparation of 26, 26, 26, 27, 27, 27-hexafluoro-1 alpha, 25-dihydroxycholesterol. (1983) (0)
Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid (2017) (0)
A new tritium-release assay for 25-hydroxyvitamin D-1 alpha-hydroxylase. (1987) (0)
1,25-Dihydroxyvitamin D (1,25-D) and ionized calcium (Ca++): Response to bovine parathyroid hormone (bPTH) in hormone deficient hypoparathyroid (HP) children (1982) (0)
Vitamin D3 as a possible chemopreventive and therapeutic agent of cancers. (1996) (0)
2-methylene-18,19-dinor-1alfa-hydroxy-homopregnacalciferol and uses thereof (2005) (0)
Synthesis and biological activity of 25xi,26-dihydroxycholecalciferol. (1975) (0)
MECHANISMS OF CALCIUM TRANSPORT IN SMALL INTESTINE (2012) (0)
Abstracts of the 1st International Conference on Steroids and Bone. Florence, Italy, May 19-21, 1994. (1994) (0)
Vitamin D in Renal Diseases (1984) (0)
Analogs of 1,25-Dihydroxyvitamin D3 and 25-Hydroxyvitamin D3 (1979) (0)
17,20 (e) dehydro vitamin D uses. (2005) (0)
New compounds derived from vitamin D (1981) (0)
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a synthetic peptide containing the NR2 box of DRIP 205 (2004) (0)
NEWS AND NOTICES (1971) (0)
D3:Short- andlong-term effects onboneand calcium metabolism inpatients withpostmenopausal osteoporosis (1982) (0)
Synthesis of LHydroxy [ 6-3 H ] vitamin D , and Its Metabolism to lar , 25-Dihydroxy [ 6-3 H ] vitamin D , in the Rat * (2002) (0)
24-epi-1alpha, 25-dihydroxylated vitamin D 2 derivatives and the compositions for pharmaceutical use containing them (1985) (0)
Regulation of vitamin D metabolism: a new dimension in calcium homeostasis. (1972) (0)
Analogs Des-C, D of 1alpha, 25-dihydroxy-19-norvitamin D3 (2006) (0)
Analogifremgangsmaade for preparing 26,26,26,27,27,27-hexafluoro-1alpha, 25-dihydroxycholecalciferoler and 26,26,26-27,27,27-hexafluoro-1alpha, 3beta, 25-trihydroxycholest-5,7 diene for use as starting material in the process (1983) (0)
1 alpha-hydroxycholecalciferol and process for its preparation (1972) (0)
Methyl ester 25, 26, 27-trinor-1a, 2b-epoxy-cholesta-4,6-diene-3-one-24-oic (1983) (0)
Hormones derived from vitamin D: Their regulation and function (1976) (0)
Vitamin D-dependent calcium transport. (1985) (0)
Synthesis of Some Side‐Chain Homologues of 1α,25‐Dihydroxyvitamin D3 and Investigation of Their Biological Activities. (1987) (0)
VITAMIN D SCIENCE, WARF, AND UNIVERSITY OF WISCONSIN-MADISON (2013) (0)
A NEW METABOLITE OF VITAMIN D_2 AND BIOLOGICAL ACTIVITIES OF ITS ANALOGS (1987) (0)
MECHANISMS OF ION TRANSPORT AT THE SUBCELLULAR LEVEL WITH SPECIAL EMPHASIS ON THE ACTION OF PARATHYROID HORMONE. Progress Report, January 1, 1967--September 1, 1967. (1967) (0)
Contents, Vol. 18, 1983 (1983) (0)
Monoclonal antibodies to human vitamin D-binding protein (hybridoma/radiometric immunosorbent assay/enzyme-linked immunosorbent assay) (0)
The use of 1,25-dihydroxycholecalciferol [1,25-(OH)2D3] in the treatment of rickets with neonatal liver disease (1978) (0)
Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3. (1999) (0)
Biological activity of 1,25-dihydroxyvitamin D sub 2 and 24-epi-1,25-dihydroxyvitamin D sub 2 (1988) (0)
PROLONGATION OF RAT KIDNEY ALLOGRAFTS USING 1,25(OH)2D3 AS THE SOLE IMMUNOSUPPRESSIVE AGENT.: Abstract# 318 Poster Board #‐Session: P165‐I (2000) (0)
Methyl ester of the acid 25, 26, 27 -trinor-1a, 2b-epoxy-cholesta-4,6-diene-3-one-24-oic acid (1983) (0)
Cloning of the mouse 25-hydroxyvitamin D(3)-1alpha-hydroxylase (CYP1alpha) gene. (2000) (0)
25-Hydroxydihydrotachysterol 3 . Biosynthesis in vivo and in vitro. (1971) (0)
CHAPTER 7 – Vitamin D and Bone* (1972) (0)
Purification and properties of vitamin D hydroxylases. (1980) (0)
Synthesis of Novel 20-Oxo-pregnacalciferol Analogues with Binding Affinity to the Progesterone Receptor. (1996) (0)
Can Sodium Fluoride Treatment Cause Spinal Fractures? (1990) (0)
Use of the vitamin D compounds to prevent transplantatafstödning (1998) (0)
Assay of 1,25-dihydroxyvitamin D3 from serum samples: use of receptor-binding or enzyme-coupled reporter analysis. (1997) (0)
Synthesis anddetermination ofconfiguration ofnatural 25-hydroxyvitamin D326,23mlactone* (vitamin Dmetabolite/iodolactonization/phenylselenolactonization) TADASHI EGUCHIt, SUGURUTAKATSUTOt, MASAJI ISHIGUROtt, NOBUOIKEKAWAt, YOKOTANAKA§, AND (1981) (0)
19-NOR VITAMIND COMPOUNDS (2017) (0)
Vitamin D in Health and Disease (1982) (0)
Compounds D-anti-vitamin and pharmaceutical compositions containing them (1979) (0)
Characterization of specific cytosol 1,25-dihydroxyvitamin D3 binding protein from chick kidney cells in culture (1980) (0)
The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1 α , 25-1 dihydroxyvitamin D 3 2 3 (2014) (0)
A bioassay capable of detecting 1 picogram of 1,25 dihydroxy vitamin D3 (1976) (0)
1966 Annual Meeting program and abstracts (1966) (0)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF (22E,24R)- AND (22E,24S)-1α,24-DIHYDROXY-22-DEHYDROVITAMIN D3 (1985) (0)
1,25-Dihydroxyvitamin D3 (1,25{OH}2D3)-treated hypoparathyroidism (HP): 29 patient years in 9 children (1980) (0)
Vitamins | Vitamin D (2021) (0)
1,25-DIHYROXYVITAMIN D3-INDUCED PROLONGATION OF GRAFT SURVIVAL WITHOUT INCREASED SUSCEPTIBILITY TO OPPORTUNISTIC INFECTION MAY BE MEDIATED BY ALTERED ANTIGEN PRESENTATION (1998) (0)
Dihydroxyvitamin D Required for Reproduc 4 , 970 , 203 Nov . 13 , 1990 11 Patent Number : 45 Date of Patent : tion ? (2017) (0)
PowerPoint Slides for: 2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial (2016) (0)
A method for locking the vitamin D compounds 1alfa-OH group in an axial orientation (2000) (0)
Synthesis of 1alpha-hydroxyergocalciferol. (1977) (0)
New compounds derived from vitamin D, their process for the preparation and pharmaceutical compositions containing these compounds (1989) (0)
443 THE EFFRICACY AND SAFETY OF 10<-ANALOGS OF VITAMIN D IN PSEUDOHYPOPARTHYROIDISM (PHP) (1985) (0)
Use of the 2-carbon-modified-19-nor-vitamin D analogs to induce the formation of new bone (2003) (0)
Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism. (1975) (0)
[46] Preparation and biological evaluation of active metabolites of vitamin D3☆ (1975) (0)
A TP FORMATION CA USED BY ACID-BASE TRANSI TION OF SPINACH CHLOROPLASTS (2003) (0)
NEONATAL EFFECTS OF 1,25 (OH)2 VITAMIN D3 ON IONIZED Ca (iCa), Ca ABSORPTION AND PARATHYROID HORMONE(PTH) (1977) (0)
Third F. Raymond Keating, Jr., Memorial Symposium--parathyroid hormone, calcitonin and vitamin D: clinical considerations. II. Vitamin D--1973. (1974) (0)
Vitamin D research--First International Congress on Vitamins and Biofactors in Life Sciences. (1992) (0)
Vitamin D metabolism: recent developments. (1973) (0)
Preparation of 19-nor-vitamin d compound and intermediate used for that method (1992) (0)
The vitamin D story: a tribute to Harry Steenbock, the scientist, the inventor and the teacher (1979) (0)
The 24 hydroxylation of 25-hydroxyvitamin D3 and 1,25 dihydroxyvitamin D3 in rat intestine (1978) (0)
Vitamin D and Multiple Sclerosis ( 44153 A ) (2008) (0)
Cell differentiation inducer (1992) (0)
Contents, Vol. 15, 1981 (1981) (0)
1,25-Dihydroxycholecalciferol: Isolation, Identification, Regulation and Mechanism of Action (1972) (0)
Bone and Bone Disease (1975) (0)
Once weekly administration of 25-hydroxy vitamin D 3 for maintaining an elevated blood level concentration at steady state pharmaco-kinetics (2009) (0)
Method for preventing and treating kidney disease symptoms (2010) (0)
Use of compounds of the 19-nor-vitamin D for preventing the. (1996) (0)
la , 25-Dihydroxyvitamn D 3 and la-hydroxyvitamn D 3 prolong survival time of mice inoculated with myeloid leukemia cells ( cell growth / cell differentiation / SL mouse / nude mouse / chemotherapy for leukemia ) (2003) (0)
Biology and Medicine Proceedings of the Society for Experimental PSEBM (2013) (0)
The action of various vitamin D3 metabolites on calcium and phosphorus metabolism in chick embryo calvariae (1986) (0)
Vitamin D C‐22 Aldehydes. New Key Intermediates for the Synthesis of Side Chain Modified Vitamin D Analogues. (1988) (0)
Compounds 26,28-methylene-1alpha, 25-dihydroxyvitamin D2. (1994) (0)
Henry A. Lardy (2012) (0)
17.20 (z) -dehydro-vitamin D analog and uses thereof (2005) (0)
(20S) -1alfa-hydroxy-2-methylene-19-norbishomopregnacalciferol having and uses thereof (2002) (0)
Guest editor's introduction. (2012) (0)
Modern views of vitamin D. (1981) (0)
Vitamin D3 as a possible chemopreventive and therapeutic agent of cancers. (1996) (0)
The effect of 1 alpha-hydroxyvitamin D2 on calcium metabolism in glucocorticoid-treated rats. (1985) (0)
26,28-methylene-1alpha, 25-dihydroxy-vitamin d2 connections (1994) (0)
vitamin 2-ethylidene-19-nor-compounds of 2-ethyl and d. (2001) (0)
Mechanisms of calcium transport in small intestine. Progress report, March 1, 1976--September 30, 1977. [Chickens, rats, lead] (1977) (0)
Process for the preparation of 25-hydroxy26,26,26,27,27,27, -hexafluor-cholecalciferol and intermediates hereby (1981) (0)
The use of 19-nor-vitamin D compounds to prevent hyperphosphosphatemi in patients with renal disorders (1996) (0)
General Principles of Vitamin D Action and Mechanism-Based Search for Analogs with Specific Actions (1995) (0)
Letter to the Editor (1982) (0)
Production of 1,25-dihydroxyvitamin d3 receptor protein (1992) (0)
The Mode of Action of 1α,25-Dihydroxyvtamin D_3 and Its Analogs (2001) (0)
Use of vitamin D compounds for the preparation of a cosmetic composition and application of these to improve skin texture. (1991) (0)
Regulation of Vitamin D Metabolism: The Kidney as an Endocrine Organ (1979) (0)
Compounds 2-alkylidene-19-nor-vitamin D their therapeutic uses. (2001) (0)
A process for preparing 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxycholesterol, intermediates for the carrying} guide and methods for their preparation (1983) (0)
ETHYL 13,14-DIHYDRO-13,14-METHYLENERETINOATES: ANALOGS OF ALL-TRANS- AND 13-CIS-RETNOIC ACID (1984) (0)
Structural analogs of 1alpha,25-dihydroxycholecalciferol: preparation and biological assay of 1alpha-hydroxypregnacalciferol. (1975) (0)
A method for the treatment and prevention of loss of bone mass. (1989) (0)
Analogues de 19-nor-vitamine d avec un cycle 3,2-dihydrofuran (2009) (0)
Introduction to the special issue of BoneKEy Reports on /`vitamin D and bone/' (2014) (0)
Treatment of osteoporosis with synthetic 1,25-dihydroxy vitamin D (1979) (0)
Modern views of vitamin D. (1981) (0)
ANALOGS AND THEIR USES (2017) (0)
Vitamin D derivatives and process for their preparation (1986) (0)
Studies on Organic Fluorine Compounds. Part 50. Synthesis and Biological Activity of Zoc-Fluorovitamin D3. (1986) (0)
Functions of Vitamin D (1979) (0)
weekly administration of 25-hydroxyvitamin D3 to maintain a blood concentration with high state pharmacokinetics balance (2009) (0)
17,20 (z) -dehydro vtamina dy their uses. (2005) (0)
Measurement of mammalian 25-hydroxyvitamin D 3 24 Rand la-hydroxylase ( 1 , 25-dihydroxyvitamin D 3 / 24 , 25-dihydroxyvitamin D / kidney / calcium ) (2003) (0)
VITAMIN D 3-STIMULA TED TEMPLATE ACTIVITY OF CHROMATIN FROM RAT (2004) (0)
Preparation and biological evaluation of active metabolites of vitamin D31. (1975) (0)
[Recent advances in the study of active forms of vitamin D]. (1972) (0)
New manufacturing process for 19-nor vitamin D compounds (1992) (0)
Contents Vol. 39, 2014 (2014) (0)
The impact of recent findings concerning vitamin d metabolism on clinical medicine. (1974) (0)
26-Hydroxylation of 1alpha,25-dihydroxyvitamin D3 does not occur under physiological conditions. (2001) (0)
United States Patent (2019) (0)
2-methylene-19,26,27-trinor-(20s)-1?-alpha-hydroxyvitamine d3 et ses utilisationsits uses (2005) (0)
Novel Synthesis of 2‐Substituted 19‐Norvitamin D A‐Ring Phosphine Oxide from D‐Glucose as a Building Block. (2003) (0)
(vitamin D function/calcium metabolism/bone/intestine/steroid receptors) (2016) (0)
Analogues 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D (2008) (0)
Recent advances in the molecular mechanism of action of 1, 25-dihydroxyvitamin D3 (1991) (0)
Direct C-I hydroxylation of vitamin D compounds: Convenient preparation of la-hydroxyvitamin D3, la,25-dihydroxyvitamin D3, and la-hydroxyvitamin D2 (0)
1109 LACK OF SEASONAL VARIATION IN SERUM 1, 25-DIHYDROXYVITAMIN D (1,25OH2D) LEVELS DESPITE CHANGES IN 25-HYDROXYVITAMIN D (25OH-D) LEVELS (1981) (0)
Synthesis of compounds of 1alpha-hydroxy-secosterol. (1992) (0)
Sequence specific backbone resonance assignment of Vitamin D receptor ligand binding domain (VDRLBD) complexed with 1,25(OH)2 D3 and LXXLL motif (DRIP205) (2012) (0)
Modern views of vitamin D. (1981) (0)
SERUM 1,25-DIHYDROXYVITAMIN D (1,25-(OH)2 D) LEVELS IN CHILDHOOD RENAL DISEASE (1980) (0)
Use of the vitamin D compounds for the preparation of a cosmetic composition and the use thereof for the improvement of skin conditions (1991) (0)
Iodo vitamin d3 compounds and their preparation (1994) (0)
Vitamin D research--First International Congress on Vitamins and Biofactors in Life Sciences. (1992) (0)
23-dehydro-25-hydroxyvitamine d3, process for preparing the same and pharmaceutical composition comprising the same (1982) (0)
1 and IL-4 TGF-for the Two Anti-Encephalitogenic Cytokines Is a Positive Regulator 3 1,25-Dihydroxyvitamin D (1998) (0)
Biological activities and binding properties of 23,23-difluoro-25-hydroxyvitamin D3 and its 1 alpha-hydroxy derivative. (1985) (0)
Mechanisms of calcium transport in small intestine. Progress report, June 1, 1973--March 15, 1974 (1974) (0)
Biographical memoirs: Henry A. Lardy (2012) (0)
Presence of 1.25-dihydroxyvitamin D resistance in renal failure (1992) (0)
Use of Vitamin D Derivatives in the Treatment of Postmenopausal Osteoporosis in Combination with Hormone Replace Therpy (1998) (0)
Preparation of Radiolabeled 9‐cis‐ and all‐trans‐Retinoids (1998) (0)
TECHNICAL NOTES Concentration of Calcium, Phosphorus, and 1,25-Dihydroxyvitamin D in Plasma of Dairy Cows During the Lactation Cycle 1 (1981) (0)
23-dehydro-25-hydroxyvitamin D (down arrow) 3 (down arrow) (1982) (0)
19-nor-vitamin D derivatives (1990) (0)
The effects of vitamin D on intestinal absorption of calcium (Ca) in premature infants (1978) (0)
A new radioreceptor assay for serum 1,25-dihydroxyvitamin D using monoclonal antibody against vitamin D receptor (1992) (0)
Cloning and characterization of the mouse vitamin D receptor promoter (1,25-dihydroxyvitamin Dygene structureycalcium metabolismysteroid receptor) (1997) (0)
Vitamin D metabolism and its relationship to familial hypophosphatemia. (1970) (0)
Intermediates for use in the manufacture of 1alpha, 25-dihydroxylated vitamin D 2 derivatives (1988) (0)
Vitamin D metabolism and function. (1978) (0)
New, tritium-release assay for 25-hydroxyvitamin D-1. cap alpha. -hydroxylase (1986) (0)
Use of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) in the treatment of hypoparathyroidism and pseudohypoparathyroidism (1976) (0)
Are the cytosolic binding proteins for 25-hydroxycholecalciferol artifacts? (1977) (0)
Inhibition oftheMetabolism of25-Hydroxycholecalciferol byActinomycin D andCycloheximide (1971) (0)
A process for preparing 26,26,26,27,27,27-hexafluoro-1alpha, 25-dihydroxycholesterol and intermediates for this purpose, (1984) (0)
Baculovirus-mediated expression of retinoic acid receptor type Y in cultured insect cells reveals a difference in specific DNA-binding behavior with the 1 , 25-dihydroxyvitamin D 3 receptor ( vitamin A / retinoic acid / DNA response element ) (0)
391 THE CIRCULATING PARATHYROID HORMONE (PTH) TO CALCITRIOL (1,25OH2D) RATIO: A MEANS OF EVALUATING CALCITRIOL SYNTHESIS IN DISORDERS OF CALCIUM METABOLISM (1981) (0)
Special process for preparing 26,26,26,27,27,27-hexafluoro-1alpha, 25-dihydroxycholesterol, and intermediates for use thereby (1984) (0)
Subject Index, Vol. 18, 1983 (1983) (0)
List of Contributors (2020) (0)
Efficiency of parathyroid hormone dependent magnesium and phosphate transport in mitochondria. (1966) (0)
Synthesis and determination of configuration of natural 25-hydroxyvitamin D3 26,23mlactone* (0)
Composes de 2-methylene-19-nor-vitamine d - 2 (2004) (0)
Efficacy of a Novel Vitamin D Analog (2–methylene–19–nor–(20S)–1a–hydroxybishomopregnacalciferol, DP006) for Treatment of Human Retinoblastoma in the LH Beta–Tag Mouse Model (2004) (0)
1α,24(S)-DIHYDROXYVITAMINE D2 CRISTALLINE ET PROCEDE DE PURIFICATION ASSOCIE (2000) (0)
Studies on antisera against vitamin D-metabolites (1979) (0)
1,2 5-Dih ydrox yvitamin osteodystrophy D3 in childhood hepatic (1979) (0)
Postnatal changes of vitamin D metabolites in relation to parathyroid hormone (PTH) and ionized Ca (iCa) (1978) (0)
1 , 25-Dihydroxyvitamin D 3 Receptors in Human Carcinomas : A Pilot Study 1 (2006) (0)
Management of multiple sclerosis. (1996) (0)

This paper list is powered by the following services:

Other Resources About Hector DeLuca

en.wikipedia.org

What Schools Are Affiliated With Hector DeLuca?

Hector DeLuca is affiliated with the following schools: